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ABSTRACT
Neurodevelopmental disorders such as ADHD represent a major national
problem. There are increasing numbers of students in schools requiring special education
services as a result of ADHD, and each of these students costs the U.S. education system
approximately $5,000 per year (Robb et al., 2011). There are additional societal costs
associated with the disorder, and ADHD can be debilitating for individuals with the
disorder and their families (i.e., Barkley & Murphy, 2010; Ginsberg, et al., 2013). The
most common treatments are stimulant medication and behavioral training (i.e., Pelham
& Fabiano, 2008), but recently neurofeedback (EEG biofeedback) has been receiving a
lot of press. Both the American Academy of Pediatrics and the American Academy of
Child and Adolescent Psychiatry have endorsed neurofeedback as a viable option for the
treatment of ADHD (AAP, 2012; Lofthouse, et al., 2012). Methods: The current study is
a randomized controlled study investigating the effects of LORETA neurofeedback on a
college population with ADHD. The study used a pre-test, multiple post-test design with
delayed treatment to provide stronger evidence of its effectiveness. Both qEEG and
behavioral data were collected to determine if there were changes in brain activity, and if
these changes were evident on popular measures of cognitive ability (i.e., WoodcockJohnson III) and attention (CPT-II). Results: The results indicated that following
LORETA neurofeedback treatment, participants exhibited significant changes in z-score
qEEG coherence within the prefrontal cortex. These changes were also related to changes
in performance on a verbal working memory measure, which approached significance.
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Finally, the results suggested that 25 sessions of LORETA NF are needed to affect
meaningful change.
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CHAPTER 1
INTRODUCTION
Neurodevelopmental disorders such as attention deficit hyperactivity disorder
(ADHD) represent a major national problem. First, there is a high prevalence of these
disorders in schools. In fact, according to the US Census Bureau’s American Community
Survey (ACS, 2006; Brault, 2008), an estimated 6.3% of children ages 5-15 have a
disability, which amounts to 2.8 million children in the United States. Of those, many are
children who are diagnosed with ADHD, and receive special education services under the
Individuals with Disabilities Education Improvement Act (IDEIA 2004). There are
increasing numbers of students in schools requiring special education services as a result
of this disorder, and each student diagnosed with ADHD costs the U.S. education system
an average of approximately $5,000 per year versus students without, who cost, on
average, approximately $300 each (Robb, Sibley, Pelham, Foster, Molina, Gnagy, et al.,
2011). Additionally, some studies have shown a relationship between ADHD and societal
costs such as those related to criminality and accidents (Bernfort, Nordfeldt, & Persson,
2008; Ginsberg, Långström, Larsson, & Lichtenstein, 2013; Matza, Paramore, & Prasad,
2005). In fact, the annual societal cost of an individual with ADHD is close to $15,000
(Pelham, Foster, & Robb, 2007). In addition to financial and societal concerns, ADHD
can be debilitating for individuals with the disorder. While behavioral therapies and
stimulant medications have historically demonstrated success for the treatment of ADHD,
both treatments have also demonstrated differential effectiveness in terms of identifying
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responders and non-responders (i.e., Elliott, et al., 2014; Lauth, Minsel, & Koch, 2015).
Finally, drug therapies can be risky, particularly considering the impacts of long-term use
(i.e., Wang, et al., 2013), suggesting a need for more and better treatment options.
Diagnosis and Impairment
According to the current Diagnostic and Statistical Manual of Mental Disorders
(DSM-V; APA, 2013), the key feature of ADHD is a persistent pattern of behavior (i.e.,
inattention, hyperactivity and/or impulsivity) that is developmentally inappropriate.
Historically there are three prominent theories of ADHD—Barkley’s Behavioral
Inhibition Model, the ADHD/I-ADHD/C dichotomy, and more recently, a working
memory model—that attempt to explain the underlying causal mechanisms of the
disorder (Barkley, 2003; Kofler, et al., 2010; Milich, et al., 2001; Raiker et al., 2012).
Regardless of the theory to which one subscribes, all three include an emphasis on
cognitive processing as a primary concern of the disorder. As cognition is an important
facet of everyday life, it is not surprising that individuals with ADHD experience
impairment in many areas. Indeed, the DSM-V criteria require clinically significant
impairment in daily functioning (e.g., social, academic, occupational functioning) across
two or more settings.
One way in which this manifests is in social functioning. Children and
adolescents with ADHD often experience social isolation, in that they are often rejected
by their peers (McConaughy, Volpe, Antshel, Gordon, & Eiraldi, 2011). Research has
also demonstrated that children with ADHD tend to have lower academic achievement
performance than their non-ADHD peers (Frazier, Youngstrom, Glutting, and Watkins,
2007; McConaughy, et al., 2011). Furthermore, studies have demonstrated that the
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difficulties associated with ADHD continue into adulthood (Barkley, Murphy, & Fischer,
2010; Buitelaar, Kan, & Asherson, 2011). For instance, two meta-analyses found that
individuals with ADHD tend to have lower rated self-esteem, lower educational
outcomes, lower occupational status and job performance ratings, as well as less job
stability than their non-ADHD peers. Additionally, individuals with ADHD consistently
have higher medical billing costs, and are at elevated risk for developing comorbid
psychiatric disorders, most notably substance use disorders (Bernfort, et al., 2008; Matza,
et al., 2005).
As previous research has shown, although the characteristics of the disorder may
change as an individual ages, ADHD can still impact an individual’s daily life into
adulthood (Barkley & Murphy, 2010; Barkley, Murphy, & Fischer, 2010; de Graaf et al.,
2008; Halmoy, Fasmer, Gillberg, & Haavik, 2009; Painter, Prevatt, & Welles, 2008). In
fact, symptoms of ADHD are estimated to affect five to eight percent of the general
population across the lifespan (Goldstein, 2011), and two to eight percent of college
students (Fleming & McMahon, 2012). As ADHD is often diagnosed in childhood, the
majority of the literature base is focused on children. Although recently there has been a
shift towards researching ADHD in adults, there is still a lack of well-established
research for college students with the disorder (Fleming & McMahon, 2012).
Adolescence and emerging adulthood are times of great personal growth and identity
development, which often times is accompanied by experimentation (Schlegel, 2012). As
such, risk-taking behaviors are often studied in adolescent and college populations.
Moreover, research has demonstrated a link between risk taking behaviors and executive
functions in this young-adult population (Pharo, Sim, Graham, Gross, & Hayne, 2011;
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Steinberg, 2007). Executive dysfunction, specifically, impulsivity, is also one of the core
cognitive deficits associated with ADHD. Thus, if non-clinical populations of college
students demonstrate an affinity towards risky behaviors, and individuals with ADHD are
at increased risk for engaging in risky behaviors, college students with ADHD are at even
higher risk. Specifically, inattention and poor impulse control may be highly problematic
for college students with ADHD, who endure long lectures, must organize their time and
effort to study, and are exposed to a wide variety of risky situations, such as those
associated with drinking and sexual activity (Barkley et al., 2002; Weyandt &
DuPaul,2008).
Current Treatment
Like many mental health disorders, there is no cure for ADHD. Currently, the two
most widely accepted treatments for ADHD are stimulant medication and behavioral
modification, or some combination thereof (National Dissemination Center for Children
with Disabilities [NICHCY], 2011; National Institute of Mental Health [NIMH], 2008).
In 2008, Pelham and Fabiano reviewed 46 studies that evaluated a variety of behavioral
evidence-based interventions (EBI) for ADHD, concluding that behavioral parent
training, behavioral classroom management, and behavioral peer interventions (i.e., social
skills training) are well-established EBIs for ADHD. Additionally, the National Registry
of Evidence-based Programs and Practices lists four empirically supported (behaviorbased) treatment programs for ADHD; however, none of these interventions have been
researched with a college population.
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ADHD and Neuroimaging
Furthermore, disorders such as ADHD are neurological in nature. In fact, several
studies utilizing positron emission tomography (PET), magnetic resonance imaging
(MRI), and functional magnetic resonance imaging (fMRI) have demonstrated structural
and/ or functional brain differences in individuals with ADHD (i.e., Castellanos, Giedd,
Marsh, Hamburger, Vaituzis, & Dickstein, 1996; Fonseca, Tedrus, Moraes, Machado,
Almeida, & Oliveira, 2008; Koehler, Lauer, Schreppel, Jacob, Heine, Boreatti-Hümmer,
et al., 2009; Monastra, Lubar, Linden, VanDeusen, Green, Wing, et al., 1999; SemrudClikeman, Steingard, Filipek, Biederman, Bejjen, Renshaw, 2000; and Vaiyda, Bunge,
Dudukovic, Zalecki, Elliott, & Gabrieli, 2005).
One such PET study examined dopamine transporter (DAT) dysregulation in
adults with ADHD (Spencer et al., 2007). The sample consisted of 47 adults (21 clinical,
26 control), and the final analyses were corrected for age, as the non-clinical group was
significantly younger than the clinical group. After correcting for age, the results of the
study suggested that DAT binding was 15% greater in the right caudate for the ADHD
group than the control group
(t = 7.7, df = 45, p = .008). Additionally, given that sex can moderate DAT binding, the
authors reanalyzed the data simultaneously controlling for both age and sex. The results
suggested an even larger effect in the right caudate, with 17% greater DAT binding in
males (t = 6.9, df = 24, p = .02) and 22% in females (t = 7.3, df = 21, p = .02).
Similarly, a meta-analysis of 21 MRI studies of children (ages 9-14) with ADHD,
found a number of structural differences (Valera, Faraone, Murray, & Seidman, 2007).
Across these 21 studies, the most frequently assessed variable was total cerebral volume,
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which was measured in 8 studies, and demonstrated global volumetric reduction across
studies. Indeed, there were 9 regions of interest—including total cerebral volume —that
demonstrated significant change between ADHD and control subjects across 3 or more
studies, and another 6 areas, which demonstrated significant differences between the
clinical group and controls in at least 2 studies. The areas found to be impacted the most
included: total cerebral volume, the corpus callosum, caudate, and cerebellum, as well as
the prefrontal cortex, frontal lobes, and deep frontal white matter. Notably, the right
caudate, which was implicated in the PET study described above, was found to
demonstrate significant standardized mean differences in 6 of the 21 studies.
Another more recent review article (Friedman & Rapoport, 2015) supports
numerous structural differences between individuals with ADHD and controls. Similar to
the 2007 meta-analysis, this study reports volumetric loss in the right striatum as a key
feature of ADHD. In addition, the authors cite other studies, which have shown
significant volume loss in the prefrontal cortex (PFC), parieto-temporal areas, basal
ganglia, and cerebellum (i.e., Nakao, et al., 2011; Valera, et al., 2007). Lastly, the authors
cite atypical brain development, which affects attention, cognitive control, and working
memory processes. This is consistent with the previous meta-analytic study, suggesting
that structural changes are particularly notable in the cerebellum, PFC, and right
hemisphere for individuals with ADHD.
Finally, a recent meta-analysis was conducted, comparing 55 fMRI studies of
individuals with ADHD (Cortese, Chabernaud, Proal, Di Martino, Milham, &
Castellanos, 2012). Of these, 39 studies focused on children, and the other 16 examined
adults with ADHD. The authors used activation likelihood estimation for the meta-
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analysis. Results indicated that children with ADHD exhibited bilateral hypoactivation in
the frontal regions and putamen, as well as the right parietal and temporal regions, and
hyperactivation in the right angular gyrus, middle occipital gyrus, posterior cingulate
cortex, and midcingulate cortex. Results of the adult analyses indicated hypoactivation in
the middle frontal gyrus, right central sulcus, and precentral gyrus, and hyperactivation in
the right angular gyrus and middle occipital gyrus. This suggests that both regional
hypoactivation and hyperactivation persist into adulthood for individuals with ADHD. At
minimum, frontal hypoactivation and hyperactivation of the right angular gyrus and
middle occipital gyrus seem to exist in both child and adult clinical populations when
compared to non-ADHD peers.
ADHD and QEEG
Overwhelmingly, PET, MRI, and fMRI research has suggested the existence of
both structural and functional differences in the brains of individuals with ADHD.
Studies examining differences between ADHD and non-ADHD populations using EEG
have paralleled these results, thus demonstrating the utility of EEG and/or quantitative
EEG (qEEG) in diagnostic clinical evaluations for ADHD. For example, Fonseca and
colleagues (2008) demonstrated differences in electroencephalographic activity between
children with ADHD and age-matched controls during an eyes closed resting state. Data
was recorded from 15 electrode sites in this study, and the authors examined absolute and
relative power across the frequency bands. First, the ADHD group exhibited greater
absolute power in delta and theta bands across the brain. Second, this group exhibited
greater absolute power in beta around the midline (i.e., C3, F4, C4 F0, C0, and P0).
Third, the ADHD group exhibited smaller relative power in the alpha 1 and beta bands at
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certain electrode sites (i.e., O1, F4; T6 respectively). Overall, the study found that qEEG
provided 83.3% sensitivity and 83.3% specificity in the diagnosis of ADHD. Another
study examined EEG differences in adults with ADHD (Koehler, et al., 2009). Koehler
and colleagues (2009) recorded data from 21 electrodes, and also examined absolute
power densities. In this study, the ADHD sample exhibited increased absolute power in
the alpha and theta bands, with no differences in beta. This suggests that the patterns of
activation, while still abnormal, may change as individuals age.
A 2015 study (Snyder, et al., 2015) examined the integration of EEG markers
(i.e., theta/beta ratio) with clinical judgment in the diagnosis of ADHD. This study was a
triple-blinded prospective study. 275 children and adolescents with attention and
behavioral problems were evaluated at 13 sites. Each of these sites had a qualified
clinician who completed differential diagnosis evaluations. A separate multidisciplinary
team comprising a psychiatrist, psychologist, and neurodevelopmental pediatrician
completed an independent consensus evaluation. Finally, separate teams collected EEG
data at each site. Clinicians identified 209/275 subjects as having ADHD. The
multidisciplinary team identified 93 less. However, 85 of these 93 also exhibited EEG
characteristics of ADHD (i.e., lower theta/beta ratio). Overall, the results of the study
indicated that the integration of EEG markers with clinical judgment could significantly
improve diagnostic accuracy by 61 to 88%.
Finally, an alternative qEEG methodology—wavelet synchronization—has been
proposed as a new approach to diagnosing ADHD using EEG (Ahmadlou & Adeli,
2010). In this study, the authors used nonlinear modeling to identify functional
connectivity deficits in a sample of children ages 7-12 (n = 47 ADHD, n = 7 control).
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Similar to the results of the fMRI studies described above, this suggests that the
distinction between ADHD and non-ADHD populations extends beyond structural
differences and into differences in function, specifically in terms of brain connectivity.
Specifically, the results of the study indicated that O2 and P4 theta, as well as T5 delta
exhibited significant differences in connectivity between the groups, suggesting deficits
in visual and auditory processing as well as data integration. This is consistent with the
results of a 2012 study (Ahmadlou & Adeli, & Adeli, 2012) in which the authors found
that differences in left-hemisphere connectivity, within the delta range, could differentiate
between ADHD and non-ADHD individuals. This methodology has also been used in the
diagnosis of epilepsy and seizure disorders (Faust, Acharya, Adeli, & Adeli, 2015)
demonstrating again that qEEG is a useful diagnostic tool for a number of neurologicallybased psychological disorders, which are summarized in Table 1.1.
QEEG as Treatment for ADHD
One of the greatest benefits of qEEG is that it provides not only a means of
identifying disorders but it can also be extended for use in treatment. One area of
research, neurofeedback (NF), does just that. In fact, NF has shown great promise in
treating neurodevelopmental conditions, because it purportedly directly impacts brain
functioning. Some researchers claim it is based on the scientific foundation of operant
learning, where behavior is increased or decreased based on the consequences of
behavior (e.g., Sterman, 2000, Thatcher, 2000) while others claim it is a form of selfregulation training (e.g., Decker, Roberts, & Green, 2014; Johnston, et al., 2010).
Regardless of the theoretical underpinnings to which one subscribes., NF uses
electroencephalography (EEG) to monitor cortical activity by placing small electrodes on
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the scalp, via a fabric cap, or geodesic net. These electrodes detect very small electrical
currents that are then amplified and recorded with the use of a computer. Like other
forms of biofeedback, the subject is then provided with feedback (i.e., visual and/or
auditory stimuli) contingent upon the brain activity detected. Low-resolution brain
electromagnetic tomography (LORETA) is a more advanced form of NF that extends
surface EEG NF. It works by using data from 19 (or more) electrodes to localize cortical
and subcortical current densities.
For example, the dorsal and ventral attention networks, as well as the default
mode network (Janssen et al., 2015; McCarthy, et al., 2014), have been implicated in
ADHD. Each of these networks involves multiple areas of the brain. For example, the
dorsal attention network includes the intraparietal sulcus and frontal eye fields (i.e.,
Brodmann Area [BA] 8), whereas the ventral attention system is made up of the ventral
frontal cortex (i.e., BA 44, 45, 47) and the temporoparietal junction (Vossel, Geng, &
Fick, 2014). The Default Network, on the other hand, is a much more vast and diffuse
network, which comprises Brodmann Areas 8, 9, 10, 21, 23, 24, 28, 29, 30, 31, 32, 36,
39, and 40 (Buckner, et al., 2008; Thatcher, North, & Biver, 2014). Although these areas
are oft associated with ADHD, research has demonstrated that other areas of the brain are
also related to attentional difficulties (i.e., BA 10, 11, 22, 23, and 24; Gitelman et al.,
1999). In looking at all of the possible brain regions, which could be impacted by ADHD,
it becomes increasing important to examine the needs of each individual.
The use of LORETA enables the user to identify both dorsal (i.e., cortical) and
ventral (i.e., subcortical) Brodmann areas that are exhibiting atypical patterns of
activation, based on a normative sample, which allows for targeted and individualized
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training protocols. One program, Neuroguide, compares individuals to a normative
sample of 625 participants (ages birth – 82 years). The Neuroguide software (through
which LORETA is available) also exports data on both raw EEG and Z-score metrics,
such that areas of atypical activation (i.e., those with Z ≥ 2) can be trained towards
typical activation (i.e. Z = 0). Overall, the power of LORETA to generate inferences
about, and to train subcortical areas, has the potential to greatly extend the scope and
efficacy of NF.
Neurofeedback in Clinical Practice
Neurofeedback is a biofeedback technique that facilitates self-awareness and
behavioral control by making the electrical activity of a person’s brain activity observable
on a computer screen. Although a relatively new technique, many research studies have
supported the efficacy of NF for the treatment of children with neurodevelopmental
disabilities in learning or attention (i.e., Arns, de Ridder, Strehl, Breteler, & Coenen,
2009; Beauregard & Levesque, 2006; Breteler, Arns, Peters, Giepmans, & Verhoeven,
2010; Gevensleben, Holl, Albrecht, Schlamp, Kratz, Studer, et al., 2010; Gevensleben,
Holl, Albrecht, Vogel, Schlamp, Kratz, et al., 2009; Levesque, Beauregard, & Mensour,
2006; Lofthouse, Arnold, Hersch, Hurt, & DeBeus, 2012; Logemann, et al., 2010; Lubar,
Swartwood, Swartwood, & O’Donnell, 1995; Walker, 2010).
For example, three recent studies have supported the use of NF for the treatment
of ADHD in both children and adults. The first examined changes across three groups of
children (ages 6-18) with ADHD (Duric, Assmus, Gundersen, & Elgen, 2012). In this
study, the authors compared three groups of children—those receiving NF only (n = 23),
those receiving only methylphenidate (n = 29), and those receiving a combination of both
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treatments (n = 24). The NF training in this study was operationalized as thirty 40-minute
sessions, thrice weekly. The sessions consisted of 5 minutes of baseline (i.e., alpha
training), followed by 30 minutes of beta/ theta NF training, and finally another 5-minute
baseline at the end. Results indicated significant symptom reduction for all three
treatment groups, based on parent report. Additionally, although significant differences
were not found between the treatment groups, it is notable that the NF-only group
exhibited more than twice the pre-test post-test change in attention. Overall, the authors
concluded that NF treatment is as effective as methylphenidate treatment in the reduction
of ADHD symptoms in children, based on parent-report.
A second study examined the activation of the Default Mode Network (DMN) in
12 children (age 9-15) with ADHD (Russell-Chapin, et al., 2013). All of the children
were taking stimulant medication throughout the duration of the study, and participants
were randomly assigned to receive NF treatment or no treatment [in addition to their
medication regime]. The treatment group received 40 sessions of NF training over the
course of 92 days. Results indicated that NF treatment resulted in both a reduction of
clinical symptoms as a well as a consolidation (i.e., appropriate activation) of the DMN.
The DMN was more consolidated in the treatment group than the control group,
suggesting the NF treatment impacted the consolidation beyond what time alone would
cause.
A third study, examined the effects of NF treatment of a group of 18 children
(Mage = 13.6 years) with ADHD (Hillard et al., 2013). In this study, 12 of the participants
(66.67%) were taking stimulant medication throughout the duration of the study.
Participants each completed 12 weekly sessions, consisting of 25 minutes of NF training
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each, which consisted of a “Focus/Alertness" protocol through the program Peak
Achievement Trainer®. ANOVA results indicated main effects both between (i.e. session
1 to session 12) and within sessions (i.e., from minute 1 to minute 25). Specifically, the
theta/low beta and theta/alpha ratios decreased significantly from pretest to posttest as
well as from the start of a session to the end of that same session. Additionally, these
changes generalized to participant’s performance on commonly used behavioral measures
(i.e., IVA+, Aberrant Behavior Checklist [ABC]) from pretest to posttest. Participants’
performance on the IVA+ indicated significant changes on 10 metrics, including both
visual and auditory attention metrics. Finally, parent report on the ABC showed a
significant decrease in behavior problems (e.g., hyperactivity) from pre-test (15.28 ±
3.24) to post-test (10.83 ± 2.44); t(17) = 3.189, P = .005.
On the other hand, there are have been some studies, which have not supported
the efficacy of NF for the treatment of ADHD. One such study (Ogrim & Hestad, 2013)
was a randomized pilot study of 32 medication-naïve children (ages 7-16) with ADHD.
Sixteen children received 30 sessions of 45 minute NF training (over 7-11 months), and
the other group received either methylphenidate or dextroamphetamine. Both behavioral
data (i.e., parent/teacher rating scales) and EEG data was collected. The results of the
study indicated that neither treatment exhibited significant changes in qEEG or ERP.
Additionally based on parent/ teacher ratings, the medication group exhibited significant
symptom reduction while the NF group did not.
Similarly, Vollebregt and colleagues (2013) completed a double-blind placebocontrolled study of 41 children (ages 8-15) with ADHD using individualized NF
protocols. The results of this study indicated mixed results. First, no group differences
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were found on several neurocognitive measures (e.g., digit span, sustained visual
attention). Second, although participants all demonstrated significant improvement on at
least one metric, they all also demonstrated deterioration on at least one measure. As
such, the study did not support the use of NF as a treatment for ADHD.
Although there is some conflicting evidence, most studies generally support the
use of neurofeedback in the treatment of ADHD. Furthermore, previous research has
suggested that NF is effective for treating a variety of neuropsychiatric disorders, such as,
anxiety disorders (Moradi, Pouladi, Pishva, Rezaei, Torshabi, & Mehrjerdi, 2011)
including obsessive-compulsive disorder (Sürmeli, & Ertem, 2011); depression (Baehr,
Rosenfeld, & Baehr, 2001; Choi, Chi, Chung, Kim, Ahn, & Kim, 2011); autism
(Jarusiewicz, 2002; Kouijzer, de Moor, Gerrits, Buitelaar, & van Schie, 2009); and
schizophrenia (Sürmeli, Ertem, Eralp, & Kos, 2011). However, many of the previously
published studies have methodological limitations that prevent a clear understanding of
the efficacy of the technique (Loo & Barkley, 2005). More recently, Meisel and
colleagues (2013) completed a randomized control trial comparing the long-term effects
of NF versus stimulant medication. The study included 23 children who were randomly
assigned to either a methylphenidate pharmacological intervention, or 40 sessions of NF,
twice per week for approximately 35-minute sessions. Data was collected at pre-test and
post-test, as well as a 3-month and 6-month follow-up after completion of the study.
Results suggested that the NF group exhibited a significant reduction in symptoms (i.e.,
hyperactivity, impulsivity, inattention), a significant reduction in functional impairment,
and a significant improvement in academic performance (i.e., writing, math), at the 3and 6-month follow-ups. Additionally, this group exhibited and a significant
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improvement in oppositional defiant (OD) behaviors at the 3–month follow-up, though
not at 6 months post-treatment. The methylphenidate group exhibited similar core
symptom reduction at 3- and 6-month follow-ups in addition to a reduction in functional
impairment and OD symptoms at 6-months. In directly comparing the two groups, the
authors found no significant differences between the groups; however, the results were
confounded as many of the NF group participants (N = 8) began a medication regime
prior to the 6-month follow-up. This suggests that in spite of the vast improvements in
recent years, there is still a great deal of research needed in this area.
LORETA Neurofeedback
Several studies have examined more sophisticated approaches to using NF. One
approach is LORETA, which can provide more localized targeting of brain regions in
comparison to surface EEG. One study found that LORETA NF appeared to strengthen
connectivity, and improve functioning in a nonclinical population (Cannon, et al., 2009).
Another study, examined the utility of LORETA NF with an ADHD population
(Koberda, et al., 2014). This study, an in-depth case study, demonstrated the impact of
LORETA NF on both qEEG (i.e., reduction of excessive beta) and behavioral data (i.e.,
computerized neurocognitive assessment) metrics.
However, few NF studies using LORETA under randomized control conditions
have been completed, and none to date have used a delayed treatment design. A delayed
treatment design can provide stronger evidence in support of the effectiveness of a given
intervention if both groups demonstrate change in the expected direction. Additionally, a
delayed treatment design is often considered more ethical than a waitlist design,
particularly when an effective treatment is being withheld. In fact, because of the great
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potential of NF as a therapeutic option, in 2011, the American Academy of Pediatrics
(AAP) listed NF as promising but in need of more research. However, in 2012, the AAP
elevated NF to a “Level 1-Best Support” for intervention for attention and hyperactivity
behaviors. Each year the AAP releases a report of evidence-based interventions (EBIs)
for a variety of disorders in childhood and adolescence. The level designations were
adapted from the American Psychological Association’s (APA) Task Force on Promotion
and Dissemination of Psychological Procedures. A Level-1 designation means that a
given intervention has shown efficacy in at least two randomized trials by at least two
different research teams.
Although NF has been recently gaining support as an empirically based
intervention, more research is needed, particularly in terms of LORETA NF. Previous
research (i.e., that reviewed by the American Academy of Pediatrics) has focused on
surface NF, which has been demonstrated to be effective after several sessions (i.e., 60
sessions; Koberda, et al. 2014).
The current study, on the other hand, was one of the first investigations of
LORETA neurofeedback using a randomized control research design with a placebo (or
sham) condition for the treatment of learning and attention problems. As described above,
LORETA neurofeedback is a more sophisticated NF technique intended to generate
inferences about sub-cortical structures, with the goal of training these areas. It is notable
that while LORETA can target subcortical structures, it is still largely based on
Brodmann areas, which are by definition, cortical regions. However, by targeting these
subcortical structures, it should allow for more targeted, and thus faster and/or more
effective results (Simkin, Thatcher, & Lubar, 2014; Wigton & Krigbaum, 2014).
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The Current Study
The current study aimed to overcome the methodological limitations of past
research (see Loo & Barkley, 2005), and to extend this research with a delayed treatment
design in order to provide a better understanding of the effectiveness of LORETA NF.
Specifically, the delayed treatment design provided a unique opportunity to evaluate the
dose-response rate of NF LORETA NF. Previous research suggests 20-50 sessions are
needed to demonstrate change (Arns et al., 2009; Holtmann, et al., 2009, Holtmann, et al.,
2014). LORETA NF may produce results in less time because it enables the clinician to
target select areas of impairment, which are consistent with a specific set of symptoms
and related brain regions (Simkin, Thatcher, & Lubar, 2014). Furthermore, with its focus
on ADHD in college students, the study will contribute to the literature on the disorder
with this population.
The major objective of this study was to test the effects of individualized
LORETA NF in college students who experience difficulties as a result of ADHD. This
was evaluated through three specific aims:
1. To test the hypothesis that LORETA NF can change brain activity in a sample of
college students with ADHD.
2. To test the hypothesis that changes in brain wave activity as a result of LORETA
NF, correspond to changes on behavioral tests of cognitive abilities (i.e., WJ-III
and CPT subtests);.
3. To test the hypothesis that LORETA NF demonstrates faster changes than
traditional surface NF (i.e., changes occur prior to 20 sessions).
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These specific aims were then assessed according to the following hypotheses, which are
summarized in Figure 1.1:


Treatment vs. Sham (sessions 1, 10, 25)
o Hypothesis 1: Students in both conditions will show equivalent
impairment at pretest as measured by behavioral measures of cognitive
ability and baseline qEEG;
o Hypothesis 2: Students in the NF condition will demonstrate greater
change toward normality than students in the sham condition at session 10,
as measured by:
a) Greater qEEG change toward normality (i.e., Z = 0);
b) Better performance on widely used behavioral measures of
cognitive ability;
o Hypothesis 3: Students in the sham condition, after session 10, will begin
to demonstrate changes in brain activity and cognitive performance similar
to that of students in the NF condition at session 25, as measured by:
a) Both groups exhibit qEEG change toward normality (i.e., Z =
0);
b) Both groups exhibit improved performance on widely used
behavioral measures of cognitive ability;
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Dose-Response Relationship (sessions 15, 20, 25)
o Hypothesis 4: Students in NF condition will demonstrate a continual
pattern of change toward normality from sessions 15 to 25, as compared to
students in the sham condition at session 10 (i.e., maximum placebo
effect).
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Table 1.1 Studies in which EEG/qEEG metrics linked to diagnosis of other disorders

Disorder
Alzheimer’s Disease

20

Studies
 Adeli, Ghosh-Dastidar, & Dadmehr (2008)
 Gawel, Zalewska, Szmidt-Sałkowska, & Kowalsi (2009)
 Herrmann & Demiralp (2005)
Antisocial Personality Disorder
 Calzada-Reyes, Alvarez-Amador, Galán-García, Valdés-Sosa (2012)
Autism
 Ahmadlou & Adeli (2014)
 Cantor & Chabot (2009)
 Sheikhani, Behnam, Mohammadi, Noroozian, & Mohammadi (2012)
Epilepsy/ Seizure Disorders
 Leach, Stephen, Salveta & Brodie (2006)
 McGonigal, Oto, Russell, Greene & Duncan (2002)
 Croona, Kihlgren, Lundberg, Eeg-Olofsson & Edebol- Eeg-Olofsson (1999)
 Faust, Acharya, Adeli, & Adeli (2015)
 Mormann, Lehnertz, David & Elger (2000)
Learning Disabilities
 Cantor & Chabot (2009)
 Rocha, Massad, Thomaz, & da Rocha (2014)
Mood Disorders
 Begić, et al. (2011)
 Koek, et al. (1999)
Schizophrenia
 Boutros, et al. (2008)
 Knyazeva, et al. (2008)
Traumatic Brain Injury
 Bozorg et al. (2010)
 Duff (2004)
 Roberts, Englund, & Scherr (2011)
 Ronne-Engstrom & Winkler (2006)
 Thatcher et al. (2001)
 Thatcher, et al. (1989)

Sham
Group

Pretest

Session
5

Session
10

Session
15

Session
20

Post-test

Treatment
Pretest
Group

Session
5

Session
10

Session
15

Session
20

Post-test
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Figure 1.1 Study Hypotheses. This figure illustrates the four study hypotheses. Red = hypothesis 1
(equivalence at pretest), green = hypothesis 2 (group differences at session 10), blue = hypothesis 3
(group differences at post-test), orange = hypothesis 4 (dose-response relationship).

CHAPTER 2
METHODS
Participants
Participants for this study included 16 college undergraduates who were
documented as having a diagnosis of ADHD. Participants were recruited through the
university’s participant pool, flyers posted around campus, newspaper advertising, and
word-of-mouth. Each participant was randomly assigned to a treatment condition. Eight
participants were randomly assigned to the sham (placebo) condition and eight
participants were randomly assigned to the neurofeedback (NF) treatment condition.
Participants received course credit for the initial screening process, and $125 for the
completion of the sessions.
Inclusion/ exclusion criteria. In order to qualify for the study, participants were
required to complete screening questionnaires documenting their diagnosis of ADHD.
These included questions regarding the age at which they were diagnosed, the type of
professional that made the diagnosis, possible comorbid conditions, and self-reported
symptoms, as well as providing documentation regarding any stimulant medication they
were currently prescribed. Additionally, they completed a baseline QEEG, and using the
Neuroguide symptoms checklist, it was determined if there were matches between
reported symptoms and QEEG abnormalities. Only those students who exhibited QEEG
abnormalities consistent with ADHD continued in the study. As the study took place
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during the academic year, it was not practical to ask students to discontinue their current
treatment plan; however, an attempt was made to covary medication status.
Participant attrition. The use of college students allowed for easy access to
follow-up with participants as well as to replace them as the need arose. Additionally,
participants received course credit (or extra credit) for participation in research as well as
remuneration in the hopes of retaining as many participants as possible. Using a college
population and having multiple sources of compensation greatly increased the potential to
successfully recruit participants and to complete the study within a reasonable time
frame. However, twenty-six participants were enrolled in the study, of which 10 were
replaced due to time constraints, personal matters, and/or poor attendance to reach the
projected 16 participants.
Measures
Screening. Participants completed an online screener in order to determine initial
eligibility. This screener included demographic information, questions regarding their
diagnosis, and questions about past and current symptomatology. Demographic questions
were included in order to assess pre-test group equivalency, and to evaluate possible
covariates in later analyses. Participants were asked if they have a documented diagnosis
of ADHD, which was confirmed by other assessments measuring symptom severity.
Symptom severity. In order to assess symptomatology, two published measures
were adapted for use online. The first was Barkley’s Current Symptoms Scale—SelfReport Form (BCSS; Barkley & Murphy, 2006), which provides a measure of selfreported ADHD symptoms. This scale has 36 items, which represent DSM-IV-TR
diagnostic criteria for ADHD (APA, 2000). The first 18 items are alternating symptoms
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of inattention and hyperactivity/impulsivity. The remaining 18 items assess settings of
impairment, and comorbid symptoms of oppositional defiant disorder. Individuals were
asked to respond on a Likert-type frequency scale, ranging from 0 (never/rarely) to 3
(very often).
Although psychometric evidence for the BCSS is reported infrequently, there
have been a few studies to validate the measure with adults. For instance, the scale has
been demonstrated to discriminate moderately well between ADHD and non-ADHD
populations. Quinn (2003) found that the inattention symptoms had 75% sensitivity, and
61% specificity, while the hyperactivity/impulsivity symptoms had 69% sensitivity and
39% specificity. While these estimates are lower than desirable, it prompted additional
research into the psychometric properties of the BCSS. Most recently, Ladner,
Schulenberg, Smith, and Dunaway (2011) examined the reliability and validity of the
scale with more than 600 university students. Ladner and colleagues reported moderately
high internal consistency coefficients for both inattention (Cronbach’s  = .88) and
hyperactivity/impulsivity (Cronbach’s  = .82). Additionally, Cronbach’s  = .91 for the
entire scale. The study also investigated concurrent validity of the BCSS with the
Conner’s Adult ADHD Rating Scales-Self Report Long Form, and the Adult Attention
Deficit Disorders Evaluation Scale. Results indicated that the BCSS correlated
moderately to highly (r = .58 - .87) with both of these measures. Although ideally,
measures would demonstrate consistently higher reliability and validity coefficients (i.e.,
above .7), this measure is based on the DSM-IV-TR criteria, thus making it clinically
relevant.
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The second scale, the Barrett Impulsiveness Scale (BIS; Patton, Stanford, &
Barratt, 1995), is a 30 item, self-report measure, which provides an assessment of
impulsivity. Now in its eleventh edition, the BIS has been used extensively in research
and clinical practice for more than 50 years, and is arguably the gold standard for
measuring symptoms of impulsivity (Malloy-Diniz, Fuentes, Leite, Correa, & Bechara,
2007; Stanford, Mathias, Dougherty, Lake, Anderson, & Patton, 2009). Factor analyses
of the current edition of the BIS, identified six sub-traits of impulsivity—attention,
cognitive complexity, cognitive instability, motor, perseverance, and self-control—that
are subsumed under the three second order factors of attention, motor, and non-planning.
Impulsivity is a symptom of ADHD, and as such was of relevance to the current study,
particularly as the population of interest is college students. To complete the scale,
individuals were asked to respond on a Likert-type frequency scale ranging from 1
(never/rarely) to 4 (almost always/always).
Stanford et al. (2009) provide the most recent and comprehensive evaluation of
the psychometric properties of the BIS-11. In fact, the study included measures of
reliability and validity for total scores, as well as for each of the first and second order
factors. Internal consistency (Cronbach’s  = .83) and test retest reliability (Spearman’s
Rho = .83) were acceptable for the entire scale; however, the reliability estimates were
lower for the individual factors (Cronbach’s  = .27 - .74, Spearman’s Rho = .23 - .74).
Intercorrelations among the subscales were also reported, ranging from r = .16 - .91. In
addition to reliability, the authors evaluated the concurrent validity of the measure with
four other impulsivity scales (e.g., Zuckerman Sensation Seeking Scale, Eysenck
Impulsiveness Scale, Behavioral Inhibition/Activation Scales, and Behavioral Measures
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of Impulsiveness). The BIS-11 significantly correlated (r = .10 - .63) with all but the last
of these, though that study included a solely non-clinical population.
These measures were used to confirm diagnosis and to assess symptom severity,
not to determine inclusion for the study. As neither of these measures were intended for
diagnostic purposes, a cut-score was not used. Instead, scores were used on a continuum
to indicate symptom severity for both groups. The original demographic survey and
copies of both screening measures are included in Appendix B.
Outcome measures.
Quantitative electroencephalography. EEG and qEEG have demonstrated a high
degree of both reliability and validity in the medical field, and more recently in
psychology. There are several types of measurements within the context of qEEG, though
only absolute power and coherence will be analyzed in this study. Absolute power refers
to the amount of voltage recorded within each band (i.e., delta, theta, alpha, beta,
gamma), and has been extensively researched, and demonstrated to be highly reliable
(i.e., r ≥.9) for both split-half and test- retest reliability (Thatcher, 2010). Coherence on
the other hand, refers to the communication between brain regions. Coherence has also
been shown to be reliable (r ≥.8) across several studies (i.e., Corsi-Cabrera, Solís-Ortiz,
Guevara, 1997; Corsi-Cabrera, Galindo-Vilchis, del-Río-Portilla, Arce, & Ramos-Loyo,
2007; Thatcher et al.,1986) with some studies reporting reliability coefficients as high as
r = .95 (Fernández, Harmony, Rodríguez, Reyes, Marosi, & Bernal, 1993; Corsi-Cabrera
et al., 2007). With regards to validity, less research has examined absolute power or
coherence alone, but qEEG has been shown to have high sensitivity (as high as 96%) for
correctly identifying individuals with post-concussion syndrome disorder (Duff, 2004).
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Additionally, in 2001, Thatcher and colleagues also developed a discriminant function to
classify traumatic brain injury patients based on symptom severity, which was validated
based on its consistency with emergency department admission measures (e.g., Glasgow
Coma Scale) and post-trauma neuropsychological testing results. For an in-depth review
of the reliability, clinical utility, and validity literature, see Roberts (2012).
Working memory. Cognitive deficits, specifically in working memory, are
common in individuals with ADHD (Alderson, Rapport, Hudec, Sarver, & Kofler, 2010;
Kofler, Rapport, Bolden, Sarver, & Raiker, 2010; Martinussen, Hayden, Higg-Johnson, &
Tannock, 2005; Rapport, Bolden, Kofler, Sarver, Raiker, & Alderson, 2009). As such,
this study included three measures of short-term/ working memory. This study used the
Woodcock-Johnson Tests of Cognitive Abilities, Third Edition (WJ III COG). The
Woodcock-Johnson Tests are held in high esteem due to their performance in various
reliability and validity analyses that have been conducted, both by the test developers and
external researchers. For instance, the core subtests have median reliability coefficients of
r11 = .81 - .94 (McGrew, Schrank, & Woodcock, 2007). Additionally, according to
Flanagan, Ortiz, & Alfonso (2007), the WJ tests are the most comprehensive of the
mainstream intelligence batteries, because they include measures of all of the CattellHorn-Carroll (CHC) broad abilities. Furthermore, the WJ III COG has been shown to
produce reliable and valid results across a variety of ages and cultures (Edwards &
Oakland, 2006; McGrew, Schrank, & Woodcock, 2007, Taub & McGrew, 2004).
As the construct of interest is working memory (Gsm), only scores from the
numbers reversed, memory for words, and auditory working memory subtests were used.
The median reliabilities (ages 2 – 90) for the three subtests are as follows: numbers
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reversed, r11= .87, memory for words, r11 = .80, and auditory working memory, r11 = .87.
Furthermore, the authors provide reliabilities for these subtests for individuals’ ages 18,
(r11 = .87, .74, .86) 19 (r11 = .86, .80, .88), and 20 – 29 (r11 = .87, .78, .80) respectively.
Additional information regarding the psychometric properties of the WJ III COG (i.e.,
intercorrelations, content and construct validity, and validity studies for specific
subpopulations) is available in the Technical Manual (McGrew, Schrank, & Woodcock,
2007).
Attention. Another core executive function deficit associated with ADHD is
sustained attention (Christakou, Murphy, Chantiluke, Cubillo, Smith, Giampietro, et al.,
2012; Tillman, Bohlin, Sorensen, & Lundervold 2009). As such, a computerized
sustained attention task was administered. The Conners’ Continuous Performance Test,
Second Edition (CPT-II) is one of the most widely used continuous performance
assessments available. The administration of this test takes approximately 15 minutes,
during which individuals were asked to discriminate between stimuli presented on the
screen. Individuals were instructed to press the space bar when presented with target
stimuli, and to suppress this behavior when a non-target stimulus was presented. The test
provides a number of performance measures (i.e., reaction time, omission errors,
commission errors), each of which have been independently evaluated for reliability and
validity.
Psychometric data from the original standardization sample is provided in the
Technical Manual (Conners, 2000). Split-half reliabilities for the three most commonly
used metrics (i.e., reaction time, omission errors, commission errors) were r = .95, r =
.94, and r = .83, respectively. Test-retest reliabilities were lower (r = .55, r = .65, and r =
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.84), though still acceptable for many metrics. The author also conducted discriminant
validity studies prior to initial publication, and found that the CPT significantly
discriminated between ADHD, neurologically impaired, and non-clinical populations on
all metrics. Finally, the manual reports the precision of the CPT in classifying ADHD
versus non-clinical adults (sensitivity = 82%, specificity = 83%).
Equipment
Hewlett Packard laptops were used during data collection and analysis. Additional
Dell desktop computers were used during the data analysis phase as well. The Brain
Master Discovery 24E amplifier (Brainmaster Technologies, Inc., Bedford, OH;
Discovery version 3.4) was used to record raw EEG data. The Brain Master Discovery
24E amplifier was selected as a result of its compatibility with Neuroguide (Applied
Neuroscience, Inc., Largo, FL), which was used to collect the raw EEG data and to
produce the quantitative EEGs (qEEG). Indeed, this amplifier has been used in a number
of similar studies in conjunction with Neuroguide (i.e., Donaldson, et al., 2012;
Luangboriboon, Tantayanon, & Wongsawat, 2013), and this combination of software was
recommended in a recent textbook chapter entitled Optimal Procedures in Z-Score
Neurofeedback (Lubar, 2014).
As described in Wigton & Krigbaum (2015), the Brain Master Discovery 24E
amplifier has an EEG bandwidth of .43 to 80 Hz, and an A/D conversion of 24 bits.
Additionally, while the amplifier has the capacity to sample at 1024 samples per second,
the data rate to the computer is much slower (i.e., 256 samples per second). Furthermore,
as described in Wigton & Krigbaum (2015), the Neuroguide acquisition module employs
a high-pass filter at 0.5 Hz and a low-pass filter at 50Hz in order to filter out noise due to
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other electronic devices in the laboratory (e.g., other computers, cell phones, building
generators).
MATLAB 2007b (Mathworks, Inc.), Microsoft Office 2013, R (The R Foundation
for Statistical Computing, 2004-2013), and IBM SPSS Statistics v. 22 were used for final
data organization and analysis.
Research Design
This study employed a pre-test, multiple post-test, delayed treatment design with
random assignment. The subjects were randomly assigned to one of two groups—a
treatment and sham condition. At baseline, subjects completed a quantitative EEG
(qEEG) in addition to a number of psychoeducational measures. These measures were
completed again halfway through the study to examine whether the treatment group was
making progress above that of the sham group. At the mid-point, the sham group began
receiving the treatment series in order to provide a secondary assessment of the treatment.
Both groups then completed post-test measures at the end of the study as well to again
examine group differences.
Neurofeedback condition. Participants in the randomly assigned NF condition
received LORETA Z score biofeedback of the default mode and attention networks
following the first administration of the cognitive battery and the EEG baseline data
collection. The baseline QEEG was used to identify Brodmann areas at a Z ≥ 2.0 entry
criteria that were consistent with a diagnosis of ADHD. In order to target both the default
mode and attention networks within the constraints of the software, two symptoms were
selected for all participants—attention difficulties and executive function deficits. This
resulted in 24 possible areas to be trained, which covered key areas of both the default
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mode network and the attention networks. Table 2.1 provides a list of the 24 possible
Brodmann areas across hemispheres, and Table 2.2 provides a list of the matches by
participant. Participants were asked to return to the lab to complete 25 LORETA Z score
biofeedback sessions (each consisting of 20 minutes active training) over the course of
the academic year. This number of sessions was selected based on the literature,
suggesting that 20-50 sessions are needed for maintenance of the change (i.e., Fuchs et
al., 2003). The goal of these sessions was to target the identified Brodmann areas. These
Brodmann areas were then measured in real-time and the Z-tunes setting was used to
train the selected brain regions toward Z = 0. Through Neuroguide, there are three
options for Z-score neurofeedback training. These setting options include all-or-nothing,
where the individual only receives feedback when 100% of the areas being trained meet
the Z-score criteria during a set time period (i.e., window), average, where the average Zscore [computed across all areas trained] must meet the Z-score criteria to be rewarded,
and Z-tunes, which is what was used in this study. The Z-tunes option is the default, and
thus preferred, setting because it is a Gaussian Adaptive filter. This approach begins as
all-or-nothing and adapts based on the individual’s performance in order to prevent the
reinforcement of extreme (i.e., outlier) scores. The feedback criterion was set to achieve
> 60% rewards and adjusted toward smaller values as the subject progressed over
sessions. The 60% threshold was based on the suggestion of Dr. Robert Thatcher, who
created the Neuroguide software. The feedback signal was a multimedia display (i.e., a
colored dot plus music) that faded when Z scores failed to meet criteria and played when
Z scores meet the feedback criteria.
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Sham control condition. Participants in this condition received a Sham (control)
condition over the first 10 sessions. For this control, electrodes were attached and
connected to the amplifier but the “playback” option was selected so that there was no
relation between the NF EEG and the subject’s EEG. Sham participants received
feedback in the form of randomly selected baseline qEEGs from the other participants,
rather than randomly generated noise, to better simulate feedback, and to ensure the
single-blind nature of the study. After the first 10 sessions, they began to receive
contingent feedback to see if they too began to show a learning curve and/or behavioral
changes.
Procedure
Participants completed an online pre-screener providing demographic information
and symptom severity. At the initial session, participants completed informed consent,
and were given an opportunity to ask questions. They were administered the behavioral
pretest measures (WJ subtests and CPT), which were counter-balanced to account for
possible order effects. Participants were then fitted with a standard 19-channel ElectroCap, which uses the international 10-20 system for electrode placement. Impedance was
kept at or below 10KΩ for each of the electrodes, and below 5KΩ for most participants.
Additionally, ground leads were placed on participants’ ears, and impedance was kept at
or below 5KΩ. Baseline recordings were taken for three minutes each while the
participants’ eyes were open and closed. If participants’ baseline EEG recordings showed
atypicalities consistent with ADHD (i.e., exhibited matches on the Symptoms Checklist),
they were given the option to begin their first session of NF. Another eyes open baseline
was recorded for three minutes at the end of the session.
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At the start of each subsequent session, a baseline recording was taken for three
minutes while the participants’ eyes were open. Participants then completed four, fiveminute sessions of (real or sham) neurofeedback, followed by a three-minute eyes open
baseline. At the end of each session, participants were also asked to complete a brief
subjective change index, indicating if they noticed changes in a number of areas (e.g.,
positive/ negative emotions, learning, attention, language) since beginning the study.
After the 10th session, participants in the sham condition began receiving real NF, until
the end of the study. At the tenth and final (25th) sessions, participants completed the
post-test behavioral measures in addition to their 20 minutes of active treatment and EEG
eyes-open baselines. An additional eyes-closed baseline was collected at the end of these
sessions as well. A schedule of visits and the assessments given at each is included in
Appendix A.
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Table 2.1. Possible Symptom Checklist Matches

Brodmann Area
Brain Region
7
Parietal
8
Frontal
9
Dorsolateral Prefrontal Cortex
10
Prefrontal
11
Prefrontal
19
Occipital
23
Cingulate
24
Anterior Cingulate
33
Anterior Cingulate
45
Dorsolateral Prefrontal Cortex
46
Frontal
47
Frontal
Note. 12 areas across 2 hemispheres for 24 possible zones.
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Table 2.2. Symptom Checklist Matches by Participant
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Subject
BA Areas
Bands
L
L
NF_005
8, 9, 24 , 47
D
NF_006
10R, 11R, 47R
D, T
NF_007
7, 8, 9, 19R, 23, 24, 33, 45R, 46R
T, A, A1, A2, B1, B2
NF_008
7, 8, 9, 10L, 11, 19, 23, 24, 45, 46, 47L
A, A1, A2, B1, B2
R R
R
R
R
R
R
NF_009
8 , 9 , 10 , 11, 19 , 45 , 46 , 47
D, T, A, A1, A2, B1, B2
NF_010
7, 8, 9, 10, 11, 19, 23, 24, 33, 45, 46, 47
D, T, A, A1, A2, B1
NF_011
8R, 9, 10, 11, 19, 24, 45R, 46, 47
D, T, A, A1, A2, B1, B2
NF_012
10R, 11R, 47R
D
NF_013
10, 11, 46R, 47R
D
R
R
R
NF_016
8 , 9 , 10, 11, 45 , 46, 47
D, T, B1
NF_019
7, 10 L, 11, 19, 23, 45L, 47L
D, T, B1, B2
NF_020
7, 8 L, 9 L, 19
T, A, A2
NF_023
7, 8, 9, 10, 11, 19, 23, 24, 33, 45, 46, 47
D, T, A, A1, A2
NF_024
7 R, 8, 9, 10, 11, 19, 23, 24, 33, 45, 46, 47
A, A2, B1, B2
NF_025
7 R, 8, 9, 10, 11, 19R, 24, 33, 45, 46, 47
D, T, B1, B2
L
NF_026
8, 9 , 23, 24, 33,
A, A2
Note. L = only left hemisphere. R = only right hemisphere.

Total Metrics
21
9
104
123
128
193
146
6
21
51
46
16
196
91
116
66

CHAPTER 3
DATA ANALYSIS
QEEG Data Selection
Prior to conducting statistical analyses, previous research was consulted in
order to complete more targeted analyses, and to preclude the need to correct for multiple
comparisons. Prior research indicates that the prefrontal cortex (PFC) and inferior frontal
gyrus (IFG) exhibit significant differences between ADHD and non-ADHD individuals
(i.e., Friedman & Rapoport, 2015; Janssen, et al., 2015; Valera, et al., 2007). Similarly,
the participants in this study exhibited atypical patterns of behavior in those areas.
Specifically, all 16 participants received training in the PFC, and 14/16 participants
received training in the IFG. As such, qEEG analyses were focused on these two areas.
Furthermore, the LORETA NF training was targeted via Brodmann Areas;
however, the data was collected in reference to 19 electrode channels. As such, these
regions of interest were related back to the electrode metric for ease of analysis based on
previous research (Okamoto, et al., 2004; Thompson, Thompson, & Wenqing; 2013). The
following electrodes were selected to account for the designated Brodmann Areas: PFC,
including the dorsolateral prefrontal cortex and orbitofrontal cortex (i.e., BA 8, 9, 10) =
FP1, FP2, F3, F4, Fz, and IFG (i.e., BA 45, 47) = F7 and F8.
QEEG Analyses
Prior to running analyses, all EEG data was visually inspected to select a
minimum of ten seconds of artifact-free data within the first minute of each sample. Care
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was taken to select data in two-second epochs whenever possible. This allowed for the
use of the drowsiness and eye movement rejection options in Neuroguide, which helped
to eliminate artifact from the data that followed recognizable patterns due to eye
movement and/or drowsiness. Additionally, the automatic selection function was
employed, which used the ten seconds of selected data as a model to automatically select
similar data within the sample. This was done to ensure a minimum of 30-seconds of
artifact-free data for each session. Next, power and coherence metrics were calculated via
a fast-Fourier transformation. Neuroguide provided both raw scores and Z-scores (see
Thatcher, 2011) for each. However, given that Neuroguide outputs tab-delimited-text
(.tdt.) files, a simple Visual Basic Script was then used to transform these data files into
Excel (.xls) files for ease of use. The data was then aggregated across subjects and
sessions through MATLAB 2007b (Mathworks, Inc., 2007) and exported to Microsoft
Excel, SPSS, and R (The R Foundation for Statistical Computing, 2004-2013) for final
data analysis.
Group equivalency was evaluated at pretest through the use of independent
samples t-tests on the LORETA absolute current density measures. Specifically, absolute
power and coherence were examined. To minimize error due to individual differences,
particularly those due to changes in brain development in young adulthood, the Z-score
measures were selected for analysis. Additionally, given that the purpose of the study was
to train atypical patterns of connectivity toward Z = 0, the Z-score metric was deemed the
most appropriate.
To examine group differences across time, discriminant function analyses
were run separately on the z-score absolute power and z-score coherence measures at 3
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time points: at pretest, and following the completion of sessions 10, and 25. Additional
discriminant function analyses were run to further investigate the findings, and to
examine the dose-response relationship of LORETA NF.
Behavioral Data A Priori Power Analyses
Due to the small sample size, a priori power analyses were run through
G*Power (Faul, et al., 2007; 2009) in order to determine the likelihood of finding
significant ANOVA results. For the CPT, moderate to large effect sizes were used to
estimate power, given that previous studies have found similarly high effects of
neurofeedback on symptoms of inattention and impulsivity (i.e., Partial η2 = .11 – .27) on
similar tests (i.e., TOVA, IVA; Fuchs et al., 2003; Arns et al., 2009). The estimated effect
sizes for the WJ subtests ranged from small (η2= .0099) to large (η2 = .2), as previous
research into the efficacy of neurofeedback has tended to focus on measures of EEG (i.e.,
theta-beta ratios; Gevensleben et al., 2009), or ADHD symptomatology as measured by
self, parent, or teacher report (e.g., BASC, Conners; Fuchs et al, 2003; Gevensleben et
al., 2009) or continuous performance tasks (e.g., IVA, TOVA; Arns et al., 2009; Lubar et
al., 1995). Additionally, previous studies that have examined changes in cognitive
abilities, as measured by standardized measures such as the Wechsler or Woodcock
Johnson Tests, have focused on full scale IQ, verbal/ perceptual abilities, or speed of
processing, rather than on specifically measuring working memory performance. For all
of the a priori analyses, alpha was set to .05, and the correlation among the repeated
measures was set to .87, .80, and .87 and .55, .65, and .84 for the WJ III subtests and CPT
measures respectively. These estimates were based on the test-retest reliabilities provided
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in the technical manuals for the measures. Results of the power analyses are provided in
the Table 3.1.
Given that previous research has suggested that neurofeedback has large
effects on continuous performance tasks, it was anticipated that this study had sufficient
power to detect similar effects. As previous research has not yet demonstrated the effects
of NF training on the WJ measures of working memory, a range of effect sizes and power
estimates were generated. As such, with such a small sample size, it was unlikely that
small effects (η2 = .01) would be detected; however, moderate (η2 = .06) to large (η2 ≥
.14) effects should have been sufficiently powered.
Behavioral Data Analyses
Prior to conducting analyses, the data were examined for adherence to
distributional assumptions. Additionally, the two groups were assessed for pre-treatment
equivalence using an independent samples t-test.
The behavioral analyses for this project were two fold—focusing on the
between group differences on the short-term/working memory measures (i.e., WJ III) as
well as on CPT performance. As such, correlations were run to determine the need for
univariate or multivariate analyses. Correlations were also run to see if a relationship
existed between the total number of areas trained or time to completion, and performance
on the behavioral measures across time. A factor analysis was also conducted to further
examine the relationship amongst the working memory measures.
Next, in order to use a repeated measures multivariate analysis of variance
(RM-MANOVA), several other assumptions were tested. One of the first assumptions
that needed to be met was that the sample size (N = 16) needed to be larger than the
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number of variables (p = 6) to be tested, which was met. However, in considering the
data across the three time points, p = 18, and thus, the WJ and CPT analyses could not be
run simultaneously. Furthermore, in testing some of the other assumptions, it became
clear that multivariate analyses were not necessary for the CPT data, as the variables
were not significantly related across time. As such, a repeated measures Multivariate
Analysis of Variance (RM-MANOVA) was run for the WJ III subtests, and repeated
measures Analyses of Variance (RM-ANOVAs) were run for each of the CPT measures
separately. However, given that number of omission errors violated the assumption of
homogeneity of variance at pretest, a nonparametric analysis was conducted to examine
group differences on that CPT measure. Finally, post-hoc contrasts were run for measures
approaching significance in the RM-ANOVA, in order to further examine the effect of
NF treatment across time.
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Table 3.1. A Priori Power Analyses

Test

.0099
(.2)
.35

.039
(.4)
.91

WJ-III numbers reversed
(r = .87)
WJ-III memory for words
.24
.75
(r = .80)
WJ-III auditory working
.35
.91
memory (r = .87)
CPT omission errors
(r = .55)
CPT commission errors
(r = .65)
CPT Hit RT (r = .84)
Note. Table cells are estimates of observed power
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Partial η2 (Cohen’s d)
.083
.138
.2
(.6)
(.8)
(1.0)
1.00
1.00
1.00

.265
(1.2)

.98

1.00

1.00

.1.00

1.00

1.00

.53

.78

.92

.98

.85

.98

1.00

1.00

1.00

1.00

1.00

1.00

CHAPTER 4
RESULTS
QEEG Data
Correlations were run between time to completion, number of regions trained,
and the total number of metrics trained with both the z-scored absolute power and zscored coherence variables to determine if there was a need to control for any of these in
subsequent analyses. Although a handful of metrics were significantly correlated, no
patterns emerged across time, suggesting that neither time to completion nor the number
of areas trained was significantly related to the effect of LORETA treatment. As such,
these variables were not added as covariates to the analyses.
The results of the independent samples t-test indicated that the two groups were
equivalent at pretest on all (i.e., 49) z-score absolute power current densities, and on 141
of the 147 z-score coherence current densities (see Tables 4.1 and 4.2). However, with
147 comparisons, a Bonferroni correction was applied, after which none of the
differences on the coherence metrics remained significant. Additionally, the random
assignment research design allows for the assumption of probabilistic equivalence,
suggesting that any differences at pretest are by chance. Thus, the two groups were
equivalent at pretest on all qEEG metrics.
Furthermore, while seven of the z-score absolute power and fourteen of the zscore coherence variables violated the assumption of homogeneity of variance,
multivariate analyses tend to be robust to such violations, particularly with equal group
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sizes. As such, the discriminant analyses were run as described above. Similarly, the
results of the pretest discriminant function analysis (DFA) further indicated that there
were no significant differences at pretest for z-score absolute power, χ2(14) = 14.76, p ≥
.05, or coherence, χ2(14) = 9.98, p ≥ .05.
Subsequent DFA indicated no significant group differences in z-score absolute
power following session 10, χ2(14) = 8.65, p ≥ .05, or at post-test, χ2(14) = 19.23, p ≥ .05
(see Table 4.3). This suggests that LORETA NF training had no effect on z-score
absolute power. However, although each of the participants received z-score training in
absolute power, previous research has suggested that NF training is more likely to result
in changes in sensorimotor rhythm or power ratios than in absolute power (i.e., von
Carlowitz-Ghori, et al., 2015). Additionally, coherence has been demonstrated to be a
better predictor of cognitive ability (Thatcher, North, & Biver, 2005; Thatcher & Lubar,
2009). Thus the z-score coherence analyses were of primary interest.
Similar to the results of the z-score absolute power analyses, no significant group
differences were found at session 10 for z-score coherence, χ2(14) = 21.28, p ≥ .05.
However, following sessions 25, significant group differences were found, χ2(14) =
23.73, p ≤ .05 (Table 4.4). This suggests that 10 sessions of LORETA NF was not
sufficient to demonstrate change. As such, follow-up discriminant analyses were run to
examine the dose-response relationship. Specifically, analyses were run to examine the
differences between the maximum sham condition (i.e., session 10) and varying dosage
strengths for the NF treatment condition—15, 20, and 25 sessions—in order to evaluate
the number of sessions necessary to demonstrate this change. Additionally, since these
were planned comparisons, a Bonferonni correction was not necessary.
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The results of these planned comparisons suggest that 15 sessions, χ2(14) = 21.18,
p ≥ .05 and 20 sessions, χ2(14) = 18.35, p ≥ .05 were not sufficient to demonstrate
changes in coherence in the treatment group (see Table 4.5). Significant changes were
again found in comparing the sham group at maximum placebo (i.e., session 10) to the
NF group at maximum treatment (i.e.., session 25), χ2(14) = 24.22, p ≤ .05. This further
suggests that 25 sessions is the minimum number of sessions of LORETA NF needed to
demonstrate meaningful change in coherence, as the treatment group demonstrated a
significant difference following 25 sessions when compared to the sham group, both prior
to receiving treatment (i.e., max sham condition) and after receiving 5, 10, and 15 session
of NF treatment themselves (i.e., delayed treatment).
Furthermore, in exploring the standardized canonical coefficients resulting from
these analyses, a pattern began to emerge. In comparing the two groups at post-test (i.e.,
following session 25), coherence between FP1 and FP2, and FP1-F3 differentiated the
two groups across all hertz bands (i.e., delta, theta, alpha 1, alpha 2, beta 1, beta 2, and
beta 3). In the follow-up DFA, the results were nearly identical (see Table 4.6). This
suggests that 25 sessions of LORETA NF significantly affected the communication
within the anterior prefrontal cortex (i.e., orbitofrontal cortex; Brodmann Area 10) with
left lateralization within the dorsolateral prefrontal cortex (i.e., Brodmann Areas 8, 9).
Behavioral Data
The results of the independent samples t-test indicated that the two groups—sham
and treatment—were equivalent at pretest on all WJ measures. However, the two groups
were not equivalent on 2 of the 3 CPT measures—omission errors and hit reaction time
(see Table 4.7). Indeed, the sham group performed significantly better than the treatment
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group at pretest, in spite of randomized group assignment, which likely impacted the
results. Additionally, the CPT omission errors variable violated the assumption of
homogeneity of variance at pretest, resulting in a need for non-parametric tests to
examine group differences.
Next, correlations were run to examine the relationship between the three shortterm/working memory measures. The results of the initial analysis indicated that while
the WJ III scores at all three time-points were significantly correlated, the coefficients
among the measures were lower than anticipated. Indeed, the highest correlation in the
sample was numbers reversed at time 1 and time 2 (r = .84) suggesting heterogeneity in
the sample could impact the results. Thus, factor analyses were completed to further
examine the relationship between these three variables, which purportedly measure the
same construct (see Table 4.8). Results indicated at pre-test there was one working
memory factor comprising the three subtests fairly equally, for both for the sham
(eigenvalue = 2.56) and treatment (eigenvalue = 2.13) groups. The same was found at
mid-point for both groups (i.e., sham eigenvalue = 2.33; treatment eigenvalue = 2.13),
indicating no significant overall group differences after the completion of 10 sessions.
However, at post-test, the results indicated a single working memory factor for the sham
group (eigenvalue = 2.26), and two distinct factors—working memory (eigenvalue =
1.26) and short-term memory (eigenvalue = 1.02)—for the treatment group, suggesting a
significant group difference in at least one of the subtests that makes up the composite.
Additionally, the creation of a second factor for just the treatment group at time 3
suggests that this difference is driven by the memory for words subtest, which makes up
the second factor.
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These results were not supported by a repeated measures multivariate analysis of
variance (MANOVA; Table 4.9), indicating no difference between the treatment and
control groups on numbers reversed, auditory working memory, and memory for words
over time, F(6, 9) = 1.41, p = .31, partial η2 = .49. Univariate tests also indicated there
was no treatment effect on cognitive performance, for numbers reversed, F(2, 28) = 1.86,
p = .18, partial η2 = .12, for auditory working memory F(2, 28) = 1.16, p = .33, partial η2
= .08, or for memory for words, F(2, 28) = .08, p = .92, partial η2 = .006.
Due to the differing results between the factor analysis and repeated measures
MANOVA, a follow-up repeated-measures ANOVA (Table 4.10) was conducted for the
memory for words subtest independently, using the “simple” contrast with the sham
group as reference. The results indicated that group differences on this measure were in
the expected direction, and approached significance, F(1, 14) = 4.27, p = .058, partial η2
= .23. However, the study did not have sufficient power to find such an effect as
evidenced by the observed power (.49) obtained through SPSS. The complete working
memory analyses are included in Tables 4.8, 4.9, and 4.10.
Correlations were run for the CPT data as well, indicating that the three CPT
variables were not significantly related across time. As such, group differences on the
CPT measures were examined using individual repeated measures ANOVAs. There was
no statistically significant difference between the treatment and control group over time
on either of the error measures: number of omission errors, F(2, 13) = .25, p = .78, partial
η2 = .04 and number of commission errors, F(2, 13) = .1.93, p = .19, partial η2 = .23.
However, the results of the omission errors ANOVA were not interpretable due to
violations of homogeneity of variance (Levene’s test: F(1, 14) = 6.31, p = .025) and
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sphericity (Mauchly’s test: χ2(2) = 11.35, p =.003). As such Friedman’s test was run to
examine group differences in omission errors. The results of the nonparametric test (i.e.,
Friedman) were similar, indicating that there was not an effect of neurofeedback on the
number of omission errors made by participants, χ2(2) = 5.51, asymmetric p =.064. The
effect of NF on hit reaction time approached significance, F(2, 13) = .3.71, p = .053,
partial η2 = .37. However, post-hoc analysis using the “simple” contrast did not indicate a
significant group difference over time, F(1, 14) = 2.99, p = .11 partial η2 = .18,
suggesting that there is not an effect of neurofeedback on hit reaction time on the CPT.
Results are included in Tables 4.11 and 4.12.
Finally, no relationship was found between the number of areas trained and
performance on the behavioral measures at any of the three time points. The highest
correlation (r = -.26) found was for the number areas trained and memory for words
performance at time 2. Additionally, only one behavioral metric (auditory working
memory at time 2) was significantly correlated with time to completion (r = .59), though
after applying a Bonferroni correction for multiple comparisons, it was no longer
significant.
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Table 4.1. Z-score Absolute Power Independent Samples T-Test at Pretest

D_FP1
T_FP1
A 1_FP1
A 2_FP1
B 1_FP1
B 2_FP1
B 3_FP1
D_FP2
T_FP2
A 1_FP2
A 2_FP2
B 1_FP2
B 2_FP2
B 3_FP2
D_F3
T_F3
A 1_F3
A 2_F3
B 1_F3
B 2_F3
B 3_F3
D_F4
T_F4
A 1_F4
A 2_F4
B 1_F4
B 2_F4
B 3_F4
D_F7
T_F7
A 1_F7
A 2_F7
B 1_F7
B 2_F7
B 3_F7
D_F8
T_F8
A 1_F8
A 2_F8
B 1_F8
B 2_F8
B 3_F8
D_Fz
T_Fz
A 1_Fz
A 2_Fz
B 1_Fz
B 2_Fz
B 3_Fz

Sham

Treatment

M (SD)
-.83 (.64)
-.68 (.63)
-.54 (.60)
-.64 (.28)
-.64 (.42)
-.59 (.73)
-.16 (1.03)
-.92 (.61)
-.60 (.52)
-.53 (.57)
-.62 (.32)
-.63 (.58)
-.60 (.81)
-.19 (.96)
-.92 (.64)
-.42 (.75)
-.37 (.52)
-.50 (.26)
-.41 (.37)
-.43 (.62)
-.06 (.88)
-.97 (.68)
-.50 (.65)
-.38 (.48)
-.48 (.31)
-.36 (.42)
-.40 (.57)
.07 (.98)
-1.21 (.52)
-.94 (.76)
-.58 (.64)
-.72 (.34)
-.66 (.51)
-.51 (.64)
-.09 (.03)
-1.07 (.68)
-.76 (.50)
-.50 (.58)
-.69 (.38)
-.61 (.40)
-.63 (.65)
.08 (1.50)
-.96 (.65)
-.49 (.60)
-.36 (.47)
-.46 (.26)
-.37 (.40)
-.41 (.70)
.16 (1.40)

M (SD)
-.82 (.66)
-.73 (.53)
-.63 (.66)
-.59 (.80)
-.41 (1.09)
-.20 (1.27)
.32 (1.35)
-.58 (.67)
-.52 (.51)
-.58 (.65)
-.54 (.73)
-.69 (.88)
-.57 (.97)
-.29 (.95)
-.86 (.53)
-.48 (.50)
-.52 (.62)
-.40 (.88)
-.37 (1.05)
-.35 (1.08)
-.08 (.99)
-.73 (.70)
-.48 (.47)
-.51 (.65)
-.45 (.83)
-.43 (1.04)
-.31 (1.16)
-.04 (1.16)
-1.04 (.55)
-1.02 (.46)
-.85 (.70)
-.80 (.86)
-.44 (1.3)
.21 (1.92)
.60 (2.12)
-.97 (.72)
-.84 (.40)
-.79 (.51)
-.82 (.73)
-.77 (.75)
-.69 (.80)
-.35 (1.17)
-.80 (.65)
-.44 (.54)
-.46 (.58)
-.41 (.78)
-.45 (.82)
-.56 (.70)
-.15 (1.03)

Levene’s test

t-test
t (df = 14)
-0.02
0.15
0.26
-0.17
-0.57
-0.75
-0.80
-1.06
-0.30
0.17
-0.27
0.14
-0.08
0.21
-0.19
0.18
0.52
-0.31
-0.10
-0.19
0.03
-0.70
-0.08
0.43
-0.09
0.18
-0.19
0.20
-0.64
0.26
0.80
0.24
-0.45
-1.00
-0.83
-0.31
0.33
1.04
0.46
0.54
0.15
0.64
-0.49
-0.17
0.39
-0.18
0.26
0.41
0.50

p
.99
.88
.80
.87
.58
.47
.44
.31
.77
.87
.79
.89
.94
.84
.85
.86
.61
.76
.92
.85
.98
.50
.94
.67
.93
.86
.85
.84
.53
.80
.44
.82
.66
.33
.42
.77
.75
.31
.65
.59
.88
.53
.63
.86
.70
.86
.80
.69
.63

F
0.09
0.43
0.04
7.10
5.36
1.64
1.65
0.23
0.08
0.06
4.72
0.89
0.001
0.004
0.68
1.86
0.10
4.22
3.92
1.68
0.00
0.37
1.45
0.11
4.55
3.19
2.01
0.04
0.05
1.92
0.02
4.98
4.79
5.11
3.65
0.12
1.14
0.54
4.00
2.29
0.34
1.33
0.26
0.74
0.04
5.71
1.00
0.1
1.58

p
0.78
0.52
0.85
0.02*
0.04*
0.22
0.22
0.64
0.78
0.82
0.05*
0.36
0.97
0.95
0.43
0.20
0.76
0.06
0.07
0.22
0.99
0.55
0.25
0.75
0.05
0.10
0.178
0.85
0.82
0.19
0.89
0.04*
0.05*
0.04*
0.08
0.73
0.30
0.47
0.07
0.15
0.57
0.27
0.62
0.40
0.84
0.03*
0.33
0.93
0.23

Mann-Whitney
U test
p

.88
.65

.96

.33
057
.80

.80

Note. N = 8 per group. *p  .05. D = delta, T = theta, A1 = alpha 1, A2 = alpha 2, B1 =
beta 1, B2 = beta 2, B3= beta 3. Independent samples Mann-Whitney U test used to
examine group equivalence for measures violating homogeneity of variance.
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Table 4.2. Z-score Coherence Independent Samples T-Test at Pretest

D_FP1_FP2
T_FP1_FP2
A 1_FP1_FP2
A 2_FP1_FP2
B 1_FP1_FP2
B 2_FP1_FP2
B 3_FP1_FP2
D_FP1_F3
T_FP1_F3
A 1_FP1_F3
A 2_FP1_F3
B 1_FP1_F3
B 2_FP1_F3
B 3_FP1_F3
D_FP1_F4
T_FP1_F4
A 1_FP1_F4
A 2_FP1_F4
B 1_FP1_F4
B 2_FP1_F4
B 3_FP1_F4
D_FP1_F7
T_FP1_F7
A 1_FP1_F7
A 2_FP1_F7
B 1_FP1_F7
B 2_FP1_F7
B 3_FP1_F7
D_FP1_F8
T_FP1_F8
A 1_FP1_F8
A 2_FP1_F8
B 1_FP1_F8
B 2_FP1_F8
B 3_FP1_F8
D_FP1_Fz
T_FP1_Fz
A 1_FP1_Fz
A 2_FP1_Fz
B 1_FP1_Fz
B 2_FP1_Fz
B 3_FP1_Fz
D_FP2_F3
T_FP2_F3
A 1_FP2_F3
A 2_FP2_F3
B 1_FP2_F3
B 2_FP2_F3
B 3_FP2_F3
D_FP2_F4
T_FP2_F4
A 1_FP2_F4
A 2_FP2_F4
B 1_FP2_F4
B 2_FP2_F4

Sham

Treatment

M (SD)
-.19 (1.48)
-.03 (1.72)
.28 (.79)
.22 (.63)
.21 (1.08)
.13 (1.14)
.3 (1.25)
.25 (.86)
.52 (.92)
.21 (.87)
.09 (.90)
.30 (1.04)
.18 (1.33)
.21 (1.08)
.04 (1.59)
.32 (1.43)
.23 (.81)
.12 (.72)
.16 (1.13)
.20 (1.11)
-.22 (1.21)
-.05 (.95)
.16 (.59)
-.05 (.73)
-.52 (0.5)
-.17 (.81)
-.24 (1.57)
-.12 (1.38)
.30 (1.25)
.66 (1.19)
.34 (.91)
.25 (.55)
.26 (1.06)
-.08 (1.04)
-.53 (1.4)
-.12 (1.99)
.46 (1.38)
.24 (.90)
.20 (.74)
.33 (1.06)
.28 (1.14)
.06 (1.290
0 (1.15)
.46 (1.21)
.27 (.81)
.23 (.54)
.42 (.70)
.24 (.95)
-.02 (1.13)
.49 (1.28)
.55 (1.28)
.46 (.45)
.34 (.52)
.36 (.87)
.17 (1.19)

M (SD)
-.68 (1.32)
-.21 (.64)
-.17 (.80)
-.24 (1.03)
-.33 (1.02)
-.39 (1.18)
-.21 (1.29)
.02 (.58)
.20 (.39)
-.18 (.33)
-.45 (1.09)
-.76 (1.47)
-1.07 (1.8)
-.48 (1.27)
-.19 (.97)
-.12 (.62)
-.260 (.37)
-.22 (.79)
-.68 (1.4)
-1.04 (1.71)
-.62 (1.48)
.03 (.49)
.02 (.32)
-.35 (.44)
-0.550.56
-.83 (1.39)
-1.31 (1.42)
-1.0 (1.46)
-.22 (.92)
-.09 (.70)
-.29 (.740
-.18 (.71)
-.45 (.85)
-.65 (1.14)
-.70 (1.25)
-.28 (0.75)
.04 (.65)
-.16 (.32)
-.16 (.92)
-.42 (1.06)
-.82 (1.4)
-.66 (1.46)
-.71 (1.42)
-.18 (.61)
-.13 (.56)
-.21 (.71)
-.25 (.97)
-.35 (1.38)
-.33 (1.34)
-.30 (1.5)
.24 (.56)
.06 (.31)
-.05 (.77)
-.31 (.26)
-.35 (1.49)

Levene’s test

t-test
t
.69
.28
1.13
1.06
1.02
.90
.38
.62
.91
1.18
1.09
1.65
1.58
1.17
.34
.81
1.55
.90
1.33
1.72
.59
-.22
.62
1.01
.14
1.15
1.42
1.24
.95
1.55
1.51
1.34
1.49
1.04
.26
.21
.80
1.19
.87
1.43
1.71
1.05
1.09
1.34
1.14
1.42
1.59
1.00
.51
1.14
.63
2.02
1.20
1.23
.77

df
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14

p
.50
.78
.28
.31
.32
.38
.71
.55
.38
.26
.29
.12
.14
.26
.74
.43
.14
.38
.21
.11
.56
.83
.54
.33
.89
.27
.18
.24
.36
.14
.15
.20
.16
.32
.80
.83
.45
.26
.40
.18
.11
.31
.29
.20
.28
.18
.14
.34
.62
.27
.54
.06
.25
.24
.45
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F
.02
1.74
.12
1.57
.003
.26
.03
.54
6.04
4.03
.77
3.43
3.10
.98
.37
7.91
8.34
.62
.82
3.43
1.33
2.70
4.76
1.35
.10
.83
.02
.007
.51
2.83
1.52
.02
.69
.43
.003
1.86
5.56
4.85
.35
.35
2.26
.93
.46
1.79
2.88
1.42
.79
1.28
1.12
.84
1.76
.57
1.66
1.88
.42

p
.88
.21
.73
.23
.96
.62
.87
.48
.03*
.07
.39
.09
.10
.34
.55
.01*
.01*
.44
.38
.09
.27
.12
.05*
.27
.76
.38
.88
.94
.49
.12
.24
.88
.42
.52
.96
.19
.03*
.05*
.56
.56
.16
.35
.51
.20
.11
.25
.39
.28
.31
.38
.21
.46
.22
.19
.53

Mann-Whitney
U test

.72

.88
.44

.65

.80
.23

B 3_FP2_F4
D_FP2_F7
T_FP2_F7
A 1_FP2_F7
A 2_FP2_F7
B 1_FP2_F7
B 2_FP2_F7
B 3_FP2_F7
D_FP2_F8
T_FP2_F8
A 1_FP2_F8
A 2_FP2_F8
B 1_FP2_F8
B 2_FP2_F8
B 3_FP2_F8
D_FP2_Fz
T_FP2_Fz
A 1_FP2_Fz
A 2_FP2_Fz
B 1_FP2_Fz
B 2_FP2_Fz
B 3_FP2_Fz
D_F3_F4
T_F3_F4
A 1_F3_F4
A 2_F3_F4
B 1_F3_F4
B 2_F3_F4
B 3_F3_F4
D_F3_F7
T_F3_F7
A 1_F3_F7
A 2_F3_F7
B 1_F3_F7
B 2_F3_F7
B 3_F3_F7
D_F3_F8
T_F3_F8
A 1_F3_F8
A 2_F3_F8
B 1_F3_F8
B 2_F3_F8
B 3_F3_F8
D_F3_Fz
T_F3_Fz
A 1_F3_Fz
A 2_F3_Fz
B 1_F3_Fz
B 2_F3_Fz
B 3_F3_Fz
D_F4_F7
T_F4_F7
A 1_F4_F7
A 2_F4_F7
B 1_F4_F7
B 2_F4_F7
B 3_F4_F7
D_F4_F8
T_F4_F8
A 1_F4_F8
A 2_F4_F8
B 1_F4_F8

.02 (1.36)
-.20 (1.03)
-.12 (1.04)
-.03 (.65)
-.46 (.39)
-.25 (.86)
-.17 (1.11)
-.37 (1.29)
.72 (1.01)
.82 (.74)
.59 (.59)
.47 (.33)
.44 (0.72)
.22 (.77)
.06 (.76)
.19 (1.33)
.54 (1.54)
.40 (.71)
.43 (.58)
.46 (.70)
.25 (.82)
.12 (1.04)
.41 (.77)
.54 (.54)
.22 (.69)
.16 (.47)
.21 (.63)
.39 (.69)
-.17 (.89)
.50 (.57)
.45 (.52)
.12 (.55)
-.17 (.62)
.28 (.60)
.10 (.99)
.09 (.98)
.21 (.90)
.77 (.82)
.27 (.86)
.21 (.46)
.41 (.89)
.21 (.67)
-.25 (1.16)
.56 (.44)
.61 (.40)
.26 (.68)
.38 (.32)
.52 (.22)
.57 (.32)
.30 (.71)
.17 (.67)
.18 (1.01)
.03 (.70)
-.45 (.42)
-.14 .(82)
.04 (1.17)
-.39 (1.03)
.61 (.74)
.83 (.63)
.54 (.65)
.48 (.39)
.46 (.65)

-.28 (1.29)
-.90 (.95)
-.62 (.46)
-.51 (.59)
-.48 (.52)
-.73 (.59)
-.81 (1.08)
-.52 (.98)
-.09 (.95)
0.470.32
.09 (.48)
.07 (.66)
-.13 (1.06)
-.15 (1.2)
-.21 (1.24)
-.79 (1.66)
-.07 (.59)
.06 (.36)
-.04 (.62)
-0.12 .79
-.15 (1.13)
-.11 (1.05)
.21 (.52)
.04 (.48)
-.09 (.53)
-.13 (.75)
-.23 (1.03)
-.48 (1.76)
-.18 (1.09)
.09 (.30)
.10 (.21)
-.49(.44)
-.53 (.61)
-.81 (1.38)
-1.53 (2.07)
-.93 (1.61)
-.29 (.67)
-.19 (.71)
-.32 (.77)
-.27 (.66)
-.39 (.65)
-.63 (1.30)
-.57 (1.21)
.54 (.28)
.43 (.28)
.13 (.49)
.15 (.50)
.24 (.49)
-.13 (1.24)
.07 (.81)
-.54 (.70)
-.56 (.59)
-.58 (.63)
-.55 (.71)
-.94 (.70)
-1.611.51
-.94 (1.25)
.40 (.37)
.39 (.44)
-.01 (.57)
-.12 (.74)
-.45 (1.24)

.46
1.40
1.25
1.55
.09
1.28
1.19
.27
1.65
1.20
1.84
1.50
1.27
.74
.52
1.31
1.05
1.19
1.55
1.58
.82
.45
.59
1.92
1.01
.92
1.03
1.31
.008
1.84
1.77
2.46
1.16
2.05
2.00
1.53
1.27
2.50
1.45
1.70
2.07
1.62
.53
.13
1.07
.45
1.09
1.44
1.54
.61
2.09
1.79
1.82
.36
2.10
2.44
.95
.70
1.64
1.78
2.05
1.85

14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14

.66
.18
.23
.14
.93
.22
.26
.79
.12
.25
.09
.16
.22
.47
.61
.21
.31
.25
.14
.14
.43
.66
.56
.08
.33
.37
.32
.21
.99
.09
.10
.03*
.27
.06
.07
.15
.23
.03*
.17
.11
.06
.13
.60
.90
.30
.66
.29
.17
.15
.55
.06
.10
.09
.73
.05
.03*
.36
.50
.12
.10
.06
.09
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.05
.03
4.99
.39
1.06
1.78
.09
1.23
.16
3.42
.12
1.66
1.44
3.58
4.18
.99
2.85
3.63
.03
.74
.77
.05
1.00
.84
2.65
1.53
.38
1.41
.07
5.72
7.38
.20
.06
6.38
8.77
11.03
.66
.41
.41
.42
3.08
3.81
.33
2.09
2.41
.49
.55
1.27
2.55
.18
.39
2.21
.15
1.36
.10
1.19
1.01
1.79
.80
.04
5.86
2.77

.83
.88
.04*
.54
.32
.20
.77
.28
.69
.09
.74
.22
.25
.08
.06
.34
.11
.08
.87
.41
.40
.83
.33
.38
.13
.24
.55
.25
.80
.03*
.017*
.66
.81
.02*
.01*
.005*
.43
.53
.53
.53
.10
.07
.58
.17
.14
.50
.47
.28
.13
.68
.54
.16
.71
.26
.75
.29
.33
.20
.39
.84
.03*
.12

.23

.20
.16

.16
08
.16

.28

B 2_F4_F8
B 3_F4_F8
D_F4_Fz
T_F4_Fz
A 1_F4_Fz
A 2_F4_Fz
B 1_F4_Fz
B 2_F4_Fz
B 3_F4_Fz
D_F7_F8
T_F7_F8
A 1_F7_F8
A 2_F7_F8
B 1_F7_F8
B 2_F7_F8
B 3_F7_F8
D_F7_Fz
T_F7_Fz
A 1_F7_Fz
A 2_F7_Fz
B 1_F7_Fz
B 2_F7_Fz
B 3_F7_Fz
D_F8_Fz
T_F8_Fz
A 1_F8_Fz
A 2_F8_Fz
B 1_F8_Fz
B 2_F8_Fz
B 3_F8_Fz

.06 (.95)
-.04 (1.39)
.59 (.46)
.62 (.38)
.39 (.53)
.27 (.48)
.09 (1.1)
-.18 (1.85)
-.42 (1.47)
.10 (.88)
.45 (1.01)
.08 (.72)
-.37 (.38)
.03 (.88)
-.19 (.98)
-.26 (.65)
.27 (.58)
.27 (.96)
-.03 (.72)
-.50 (.53)
-.06 (.74)
-.04 (1.2)
-.27 (.88)
.37 (.81)
.81 (.92)
.39 (.87)
.38 (.54)
.41 (.94)
.03 (.73)
-.22 (.99)

-.60 (1.64)
-.51 (1.41)
.40 (.29)
.25 (.32)
.13 (.39)
-.06 (.64)
-.22 (.95)
-.58 (2.04)
-.33 (1.28)
-.94 (.89)
-.73 (.76)
-.67 (.78)
-.61 (.53)
-.70 (.36)
-.89 (.69)
-.75 (.73)
-.43 (.62)
-.39 (.62)
-.61 (.59)
-.61 (.68)
-.88 (.97)
-1.74 (1.48)
-1.13 (1.45)
-.04 (.53)
.02 (.54)
-.13 (.63)
-.26 (.66)
-.37 (.65)
-.58 (1.14)
-.49 (.97)

.98
.68
1.01
2.08
1.10
1.17
.61
.41
-.13
2.35
2.65
1.98
1.05
2.17
1.64
1.43
2.32
1.63
1.77
.36
1.91
2.52
1.44
1.20
2.09
1.37
2.14
1.91
1.28
.55

14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14
14

.34
.51
.33
.06
.29
.26
.55
.69
.90
.03*
.02*
.07
.31
.05*
.12
.18
.04*
.13
.10
.73
.08
.02*
.17
.25
.06
.19
.05
.08
.22
.59

2.18
.17
.11
.71
2.33
.82
.12
.02
.04
.08
.82
.03
.37
10.20
.53
1.33
.04
3.80
1.11
.21
.87
1.56
4.52
.87
3.83
1.64
.006
1.72
2.04
.17

.16
.69
.74
.41
.15
.38
.75
.89
.84
.78
.38
.87
.55
.007*
.48
.27
.84
.07
.31
.66
.37
.23
.05
.37
.07
.22
.94
.21
.18
.69

.16

Note. N = 8 per group. *p  .05. D = delta, T = theta, A1 = alpha 1, A2 = alpha 2, B1 =
beta 1, B2 = beta 2, B3= beta 3. Independent samples Mann-Whitney U test used to
examine group equivalence for measures violating homogeneity of variance.
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Table 4.3. Z-score Absolute Power
Discriminant Function Analyses
χ2 (df)
p
Wilk’s 
Pre-test
.12
14.76 (14) .40
Session 10
.29
8.65 (14) .85
Post-test
.06
19.23 (14) .16
Note. *p  .05
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Table 4.4. Z-score Coherence
Discriminant Function Analyses
χ2 (df)
P
Wilk’s 
Pre-test
.24
9.98 (14) .76
Session 10
.05
21.28 (14) .10
Post-test
.03
23.73 (14) .05*
Note. *p  .05
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Table 4.5. Dose-Response Z-score
Coherence Discriminant Function Analyses
χ2 (df)
p
Wilk’s 
Session 15
.05
21.18 (14) .10
Session 20
.07
18.35 (14) .19
Post-test
.03
24.22 (14) .04*
Note. *p  .05
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Table 4.6. Standardized Canonical Discriminant Function Coefficients

Post-test Analysis
1.139
4.788
-9.041
3.989
-1.223
.306
1.727
.247
-.227
2.453
2.041
-.236
2.796
-3.537

Dose Response Analysis
-5.872
2.709
2.334
-10.508
15.314
-11.792
6.472
18.616
-8.059
-10.128
7.238
-17.204
8.269

D_FP1_FP2
T_FP1_FP2
A 1_FP1_FP2
A 2_FP1_FP2
B 1_FP1_FP2
B 2_FP1_FP2
B 3_FP1_FP2
D_FP1_F3
T_FP1_F3
A 1_FP1_F3
A 2_FP1_F3
B 1_FP1_F3
B 2_FP1_F3
B 3_FP1_F3
A 1_FP1_F4
4.677
Note. D = delta, T = theta, A1 = alpha 1, A2 = alpha 2,
B1 = beta 1, B2 = beta 2, B3= beta 3
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Table 4.7. Independent Samples T-Test at Pretest for Behavioral Data

Numbers Reversed
Auditory Working Memory
Memory for Words
Omissions
Commissions
Hit Reaction Time
Note. N = 8 per group. *p  .05

Sham Condition
M (SD)
100.75 (12.08)
105.88 (13.44)
99.25 (9.74)
43.85 (2.75)
59.04 (10.73)
36.26 (6.86)

Treatment Condition
M (SD)
99.13 (15.39)
109.250 (12.75)
106.75 (12.14)
51.1075 (6.23)
55.1462 (8.02)
48.078 (9.19)

t-test
t (df)
.24 (14)
-.51 (14)
-1.36 (14)
-3.02 (14)
.82 (14)
-2.92 (14)

p
.82
.61
.19
.009*
.43
.01*

Levene’s test
F
p
.27
.04
.73
6.31
1.90
.46

.62
.85
.41
.03*
.19
.51

56

Table 4.8. Factor Analysis of Working Memory Measures

Component 1
Model 1a
Numbers Reversed
Auditory Working Memory
Memory for Words
Model 1b
Numbers Reversed
Auditory Working Memory
Memory for Words
Model 2a
Numbers Reversed
Auditory Working Memory
Memory for Words
Model 2b
Numbers Reversed
Auditory Working Memory
Memory for Words

Component 2

.948
.904
.921
.927
.809
.787

880
.926
.833
.927
.809
.787

Model 3a
Numbers Reversed
.899
Auditory Working Memory
.860
Memory for Words
.843
Model 3b
Numbers Reversed
.808
066
Auditory Working Memory
.717
-.451
Memory for Words
.299
.903
Note. Extraction Method: Principal Components Analysis.
Model 1a = sham group at pretest, Model 1b = NF group at pretest,
Model 2a = sham group following session 10, Model 2b = NF
group following session 10, Model 3a = sham group at post-test,
Model 3b = NF group at post-test
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Table 4.9. Repeated Measures MANOVA for Working Memory Measures

Effect
Between Subjects
Intercept
Condition

Wilk’s 

F (df)

p

.004

.000**

.65

976.10 (3,
12)
2.18 (3, 12)

.14

.42

.16
.52

7.68 (6, 9)
1.41 (6, 9)

.84
.31

.31

Observed Power

Within Subjects
Time
Time*Condition
Note. *p  .05 **p  .01 ***p  .001
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Table 4.10. Post Hoc Analysis with Simple Contrast: Memory for Words

Sums of Squares
F (df)
p
Observed Power
Contrast 240.25
4.27 (1, 14) .058
.49
Error
788.39
Note. Sham group was used as reference
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Table 4.11. CPT Repeated Measures ANOVAs
F (df)
p
Observed Power
Wilk’s 
Omission Errors^
.96
.25 (2, 13) .78
.08
Commission Errors
.77
1.93 (2, 13) .19
.33
Hit Reaction Time
.64
3.71 (2, 13) .053
.57
Note.^ Uninterpretable due to violation of homogeneity of variance.
*p  .05
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Table 4.12. Post Hoc Analysis with Simple Contrast: Hit Reaction Time

Sums of Squares
F (df)
p Observed Power
Contrast
281.01
2.99 (1, 14) .11
.36
Error
1314.68
Note. Sham group was used as reference
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CHAPTER 5
DISCUSSION
It was hypothesized that the two groups would not exhibit significant differences
at pre-test, the group differences would be greatest at the mid-treatment time point (i.e.,
session 10), prior to the control group receiving the treatment, and at post-test, the groups
would begin to demonstrate similar scores again, due to the nature of the delayed
treatment design.
The first hypothesis was generally supported, as the groups were equivalent at
pretest for the z-score absolute power and z-score coherence metrics. Results from the
behavioral analyses similarly indicated no significant group differences at pretest for 4 of
the 6 behavioral measures. Additionally, although the sham group outperformed the
treatment group at pretest, by chance, the scores on the omission errors measure were
within the average range for both groups, further suggesting approximate group
equivalence. The sham group’s faster reaction time is also likely related to the number of
commission errors, which was equivalent across groups. Finally, due to random
assignment and equal group sizes, the study can assume probabilistic equivalence.
The second hypothesis was not supported by the either the qEEG or behavioral
analyses as there were no significant group differences following 10 NF sessions. As
such, the results of this study are consistent with the current literature base, suggesting
that 10 sessions of training is not sufficient to demonstrate significant change.
Interestingly, previous research has indicated that a large number of sessions (i.e., 20-50;
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(Arns et al., 2009; Holtmann, et al., 2009, Holtmann, et al., 2014) are necessary for
surface NF, though it is hypothesized that LORETA NF can demonstrate faster change
(Simkin, Thatcher, & Lubar, 2014; Wigton & Krigbaum, 2014). However, the results of
this study suggest that 10 sessions of LORETA NF is still insufficient to demonstrate
meaningful change on either a qEEG metric, or on behavioral measures of cognitive
ability.
The third hypothesis was that at post-test, the sham group would begin to
demonstrate change in the same direction as the treatment group. This hypothesis was
partially supported. First, the qEEG analyses demonstrated significant change between
groups at session 25, for the z-score coherence metric. Additionally, while both groups
improved on the behavioral measures over time, the groups began to demonstrate
significant between-group differences at post-test, particularly on the verbal working
memory measure—memory for words—which approached significance, but was
underpowered. Furthermore, the factor analytic examination of the working memory data
supports the existence of group differences on the memory for words subtest, due to the
change in factor structure (i.e., emergence of a second factor for that subtest for only the
treatment group, at posttest).
Further examination of the qEEG data, by comparing the maximum placebo effect
(i.e., sham group at session 10) with the treatment group at differing points of treatment
allowed for an approximation of a dose-response relationship (i.e., hypothesis 4). This
post-hoc analysis further supported the finding that 25 sessions of LORETA NF was
necessary to demonstrate significant change across time.
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Finally, in examining the canonical coefficients from the discriminant analyses,
coherence within the prefrontal cortex—bilaterally within the left and right orbitofrontal
cortex (i.e., Brodmann Area 10) and between the left orbitofrontal cortex and left
dorsolateral prefrontal cortex—was where the most drastic changes occurred. The
prefrontal cortex is involved with cognitive control, and the secondary left lateralization
suggests possible implications for language. Memory for words is a verbal working
memory measure. The behavioral analyses approached significance, and though not
statistically significant in this study, the changes were in the expected direction, and more
importantly, the results were consistent with the qEEG changes in coherence.
Overall, results of this study suggest that 25 sessions of LORETA NF training is
needed to demonstrate meaningful changes in a college-aged ADHD population, which is
consistent with previous literature. Additionally, the consistency between the qEEG and
behavioral data is also consistent with previous research, suggesting the importance of
the left prefrontal cortex in the acquisition and maintenance of one’s verbal working
memory.
Limitations
This study has a number of limitations. First, and foremost, the small sample size
is a major limitation. Although the a priori power analyses suggested that the study was
sufficiently powered, these analyses were run for univariate models, not multivariate. As
such the small sample size, and small effect sizes likely contributed to the lack of
significant findings. However, the emergence of a second WJ factor, as well as the results
of the post-hoc ANOVA contrast suggests that the results are in the expected direction,
and thus likely just underpowered.
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Some of the outcome measures were also not ideal for this population. Although
the WJ-III Tests of Cognitive Abilities has excellent psychometric properties, it is better
at demonstrating developmental change (i.e., within a school-age population). This was
determined following the completion of phase 1 of the study, as many of the participants
exhibited a ceiling effect (i.e., scored near the maximum score prior to post-test). As
such, it is likely that the use of a different measure, one meant specifically for adults,
could have provided a better measure of change over time for working memory.
Previous research has also suggested that individuals with ADHD are highly
motivated by immediate, and personally salient rewards (Marco, et al., 2009). Subjective
report from the participants indicated that the stimuli used in the study were boring. In
fact, several participants requested to change their chosen stimuli part way through the
study, suggesting that they were no longer interested in the stimuli, and thus less likely to
maintain focus. The payment scale also seemed to be too far spread out. Future studies
should consider more frequent, smaller payments (i.e., $5 at the end of every session).
Although the larger sums seem like a greater reward, it is possible that this smaller,
consistent reward would be more meaningful, and thus help to improve the outcome(s).
Finally, this began as an efficacy study, to evaluate the efficacy of LORETA NF
for the treatment of ADHD in a college population. However, there was significant
attrition, and participant’s treatment compliance was inconsistent. For instance,
participants were asked to complete 2-3 sessions weekly for a duration of approximately
3 months, yet the average time to completion was 5.34 months. Additionally, one
participant took 11 months to complete the study, and another took 14 months, likely
resulting in little to no treatment effect due to inconsistency. Furthermore, 2 participants
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reported inconsistency in their regular stimulant medication regime, and 2 others changed
their dosage and/or the prescribed stimulant during the study. Although attempts were
made to control for this, it became too cumbersome with the sheer volume of variables.
Finally, at the completion of the study 2 participants acknowledged that they
recreationally used marijuana at some point during the study, and 1 participant attempted
to quit smoking during the study, which could have further impacted the results. As such,
what began as an efficacy study became more of an effectiveness study, demonstrating
that a college campus is likely not the best environment for LORETA NF treatment.
However, in spite of these challenges, the results were still within the expected direction,
providing even stronger support for the use of this treatment within a clinical setting.
Implications
Although the group level behavioral analyses for this study were not statistically
significant, the results are in the expected direction, and consistent with the qEEG
coherence results. Additionally, the results are consistent with other recent studies in the
field, suggesting that NF is an effective and appropriate intervention for individuals with
ADHD. Furthermore, this study is one of very few investigating the impact of NF
training with a college population, thus filling a much-needed gap in the literature.
Finally, the results of this study provide support for the use of LORETA NF with a
college-aged population with ADHD, and more importantly, demonstrate the need for 25
sessions of LORETA NF to truly affect change. Although there is hope for NF LORETA
to enable faster change, the results of this study suggest that a large number of sessions
are still needed even with this more sophisticated technique. However, 25 is still less than
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the 30-50 sessions reported in other studies of surface NF, suggesting that perhaps
LORETA NF is more efficient.
Future Directions
Given the significant limitations to this study, further investigation is needed to
examine the efficacy and effectiveness of NF training for the treatment of ADHD in a
college population. Future studies should include a larger sample size, and stricter
inclusion criteria, specifically that participants must agree to a schedule of 2-3 weekly
sessions prior to their first session. Additionally, future studies should examine more
closely the dose-response relationship in order to more fully answer the question of
whether LORETA NF is a faster and more efficient means of affecting change for young
adults with ADHD. Lastly, given the heterogeneity of ADHD, specifically the vast
differences in symptomatology and onset of ADHD-predominately inattentive type,
future studies should examine the effects of LORETA NF training on the distinct
subpopulations separately.
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APPENDIX A
SCHEDULE OF VISITS
Visit
Prior to 1st visit:
screening
1st visit: baseline
(pre-test)
2nd – 10th visits
10th visit (1st post-test)
11th-25th visits
25th visit: post-test data
collection

Tasks
Online screener (including demographics, assessment
measures)
Baseline EEG data collection, pretest measures, begin
neurofeedback or sham condition
Continue neurofeedback or sham condition
Re-administer outcome measures
All subjects getting neurofeedback
Re-administer outcome measures
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APPENDIX B
ONLINE DEMOGRAPHIC SCREENER SURVEY

OVERVIEW
What is "neurofeedback"?
Neurofeedback = EEG biofeedback = The process of changing brain functioning/
“moving” the brain toward a healthier state by using operant conditioning methods. This
is similar to "rewarding" your brain waves for firing at a target rate...like training your
brain.
Why do neurofeedback with students with ADHD?
We want to investigate whether neurofeedback is effective in changing functioning in
brain areas associated with ADHD. For example, there is previous research to suggest
large effect sizes for neurofeedback reducing impulsivity and hyperactivity in children
with ADHD (Arns de Ridder et al., 2009). We want to build on this previous research.
What do I get out of this?
1. Up to 3 hours of SONA credit (for completion of screening measures and the first
visit).
2. $125 in cash (for completion of all 25 sessions. The first 10 sessions must be
completed within 4 weeks, ideally 2-3 sessions per week for the duration of the study).
3. You will be provided with a snapshot report of your brain activity over the sessions.
What will be required of you?
1. Complete a brief online screening to determine eligibility and you may be asked to
provide written documentation, and/or complete additional questionnaires.
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2. Visit the ACN lab for 25 total neurofeedback sessions ranging from 30 minutes to 2
hours each (the first and last sessions will be the longest)
a. Capping: each session, the research team will fit you with an EEG cap. This is not
invasive, but does include application of saline gel to the scalp.
b. Fill out forms and answer questions about how you are feeling after receiving
neurofeedback (each session)
c. At the first and last sessions, perform an attention task on the computer, and
complete some measures of cognitive ability.
d. You must complete all 25 sessions. Sessions are made by appointment and if you are
unable to make the appointment, you will need to give 24 hours’ notice. (Two no-shows
is grounds for dismissal without compensation.)

CLICK HERE IF YOU ARE INTERESTED IN SEEING IF YOU ARE ELIGIBLE...

ACN Lab Neurofeedback Study
Please complete all of the information below to the best of your ability. All information
will be kept confidential.

* Required
First and Last Name*
Email Address*
Age in Years*
Do you have a medical diagnosis of ADHD?*
Yes
No
At what age (in years) were you diagnosed with ADHD?*
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Who gave you this diagnosis?*
General Practitioner/ Physician
Psychiatrist
Psychologist
Don't Know
Other:
Are you currently prescribed medication for ADHD?*
Yes
No
Please list all medications you currently take, including those for ADHD. Include dosage
and frequency (e.g., daily, twice daily, etc.)*

Please list any other current diagnoses (e.g., depression, anxiety). If applicable, include
the type of treatment. *

Are you willing and available to commit to 25 sessions of Neurofeedback?*
Yes
No

Submit
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Current Symptoms Scale
For the following questions, please select the answer that best describes your behavior
DURING THE PAST 6 MONTHS.
Fail to give close attention to details or make careless mistakes in my work*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Fidget with hands or feet or squirm in seat*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Have difficulty sustaining my attention in tasks or fun activities. *
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Leave my seat in situations in which seating is expected*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Don't listen when spoken to directly*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
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Feel restless*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Don't follow through on instructions and fail to finish work*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Have difficulty engaging in leisure activities or doing fun things quietly*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Have difficulty organizing tasks and activities*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Feel "on the go" or "driven by a motor"*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Avoid, dislike, or am reluctant to engage in work that requires sustained mental
effort.*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
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Talk excessively*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Lose things necessary for tasks or activities*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Blurt out answers before questions have been completed*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Am easily distracted*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Have difficulty awaiting turn*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Am forgetful in daily activities*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
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Interrupt or intrude on others*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
How old were you when these problems with attention, impulsiveness or
hyperactivity first began to occur?*

To what extent do the problems you may have checked above interfere with your ability to
function in each of these areas of life activities?
In my home life with my immediate family*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
In my work or occupation*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
In my social interactions with others*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
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In activities or dealings in the community*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
In any educational activities*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
In my dating or marital relationship*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
In my management of my money*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
In my driving of a motor vehicle*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
In my leisure or recreational activities*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
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In my management of my daily responsibilities *
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Instructions: Again, please check the number next to each item that best describes your
behavior DURING THE PAST 6 MONTHS.
Lose temper *
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Argue*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Actively defy or refuse to comply with requests or rules*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Deliberately annoy people*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Blame others for my mistakes or behavior*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
100

Am touchy or easily annoyed by others*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Am angry or resentful*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Am spiteful or vindictive*
0) Never or Rarely
1) Sometimes
2) Often
3) Very Often
Impulsivity Scale
People differ in the ways they act and think in different situations. This is a test to
measure some of the ways in which you act and think. Read each statement and check the
box next to the appropriate response. Do no spend too much time on any statement.
Answer quickly and honestly.
I plan tasks carefully*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I do things without thinking*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
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I make-up my mind quickly*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I am happy-go-lucky*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I don't "pay attention"*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I have "racing" thoughts*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I plan trips well ahead of time*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I am self-controlled*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
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I concentrate easily*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I save regularly*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I "squirm" at plays or lectures*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I am a careful thinker*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I plan for job security*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I say things without thinking*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
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I like to think about complex problems*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I change jobs*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I act "on impulse"*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I get easily bored when solving thought problems*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I act on the spur of the moment*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I am a steady thinker*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
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I change residences*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I buy things on impulse*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I can only think about one thing at a time*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I change hobbies*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I spend or change more than I earn*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I often have extraneous thoughts when thinking*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
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I am more interested in the present than the future*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I am restless at the theater or lectures*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I like puzzles*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always
I am future oriented*
1) Rarely/Never
2) Occasionally
3) Often
4) Almost Always/Always

Thank You
Thank you for taking the time to complete our survey.
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APPENDIX C
SUBJECTIVE CHANGE INDEX
Please indicate if you have noticed any changes in any of the following areas
since starting this study. Use the following rating scale for each area. Place an X
in the appropriate box that best represents of change in different areas.
Rating Scale
0 No Change
1 Maybe a little change
2 Some Change
3 Definitely some change
4 Definitely moderate amount of change
5 Definitely a large amount of change
0

1

2

Positive
Emotions
Negative
Emotions
Attention
Concentration
Body
Awareness
Body
Movement
Visual
Perception
Auditory
Perception
Language
Thinking
Memory
Anxiety
Sadness
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3

4

5

In your opinion do you feel there was a relationship or connection between what
you were thinking and the feedback you were receiving on the screen?

Please Circle your Answer:
0

Definitely Yes

1

Maybe

2

Probably Not

3

Definitely Not
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